{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:28:10Z","timestamp":1771327690928,"version":"3.50.1"},"reference-count":320,"publisher":"Bentham Science Publishers Ltd.","issue":"24","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>This review critically addresses the putative molecular targets of Diabetic Nephropathy (DN) and screens effective phytocompounds that can be therapeutically beneficial, and highlights their mechanistic modalities of action.<\/jats:p><\/jats:sec><jats:sec><jats:title>Introduction:<\/jats:title><jats:p>DN has become one of the most prevalent complications of clinical hyperglycemia, with individual-specific variations in the disease spectrum that leads to fatal consequences. Diverse etiologies involving oxidative and nitrosative stress, activation of polyol pathway, inflammasome formation, Extracellular Matrix (ECM) modifications, fibrosis, and change in dynamics of podocyte functional and mesangial cell proliferation adds up to the clinical complexity of DN. Current synthetic therapeutics lacks target-specific approach, and is associated with the development of inevitable residual toxicity and drug resistance. Phytocompounds provides a vast diversity of novel compounds that can become an alternative therapeutic approach to combat the DN.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method:<\/jats:title><jats:p>Relevant publications were searched and screened from research databases like GOOGLE SCHOLAR, PUBMED and SCISEARCH. Out of 4895 publications, the most relevant publications were selected and included in this article.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result:<\/jats:title><jats:p>This study critically reviews over 60 most promising phytochemical and provides with their molecular targets, that can be of pharmacological significance in context to current treatment and concomitant research in DN.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>This review highlights those most promising phytocompounds that have the potential of becoming new safer naturally-sourced therapeutic candidates and demands further attention at clinical level.<\/jats:p><\/jats:sec>","DOI":"10.2174\/0929867330666230519112312","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T05:23:05Z","timestamp":1684732985000},"page":"3752-3790","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["To Explore the Putative Molecular Targets of Diabetic Nephropathy and their Inhibition Utilizing Potential Phytocompounds"],"prefix":"10.2174","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6290-3430","authenticated-orcid":true,"given":"Banani","family":"Bhattacharjee","sequence":"first","affiliation":[{"name":"Endocrinology and Reproductive Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani, 741235, West Bengal, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4147-4651","authenticated-orcid":true,"given":"Arnob","family":"Chakrovorty","sequence":"additional","affiliation":[{"name":"Cytogenetics and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani, 741235, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maharaj","family":"Biswas","sequence":"additional","affiliation":[{"name":"Endocrinology and Reproductive Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani, 741235, West Bengal, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3604-7404","authenticated-orcid":true,"given":"Asmita","family":"Samadder","sequence":"additional","affiliation":[{"name":"Cytogenetics and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani, 741235, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9960-6584","authenticated-orcid":true,"given":"Sisir","family":"Nandi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Global Institute of Pharmaceutical Education and Research, Affiliated to Uttarakhand Technical University, Kashipur, 244713, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","year":"1995","unstructured":"Diabetes in America. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Available from: https:\/\/diabetes.org\/healthylivingnews?gad=11995","journal-title":"National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","volume":"26","author":"Genuth S.","year":"2003","unstructured":"Genuth S.; Alberti K.G.; Bennett P.; Buse J.; Defronzo R.; Kahn R.; Kitzmiller J.; Knowler W.C.; Lebovitz H.; Lernmark A.; Nathan D.; Palmer J.; Rizza R.; Saudek C.; Shaw J.; Steffes M.; Stern M.; Tuomilehto J.; Zimmet P.; Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003,26(11),3160-3167","journal-title":"Diabetes Care"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S0140-6736(06)68341-4","volume":"367","author":"Daneman D.","year":"2006","unstructured":"Daneman D.; Type 1 diabetes. Lancet 2006,367(9513),847-858","journal-title":"Lancet"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/S0140-6736(17)30058-2","volume":"389","author":"Chatterjee S.","year":"2017","unstructured":"Chatterjee S.; Khunti K.; Davies M.J.; Type 2 diabetes. Lancet 2017,389(10085),2239-2251","journal-title":"Lancet"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.taap.2012.12.018","volume":"267","author":"Samadder A.","year":"2013","unstructured":"Samadder A.; Das J.; Das S.; De A.; Saha S.K.; Bhattacharyya S.S.; Khuda-Bukhsh A.R.; Poly(lactic-co-glycolic) acid loaded nano-insulin has greater potentials of combating arsenic induced hyperglycemia in mice: Some novel findings. Toxicol Appl Pharmacol 2013,267(1),57-73","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.colsurfb.2013.03.028","volume":"109","author":"Samadder A.","year":"2013","unstructured":"Samadder A.; Das S.; Das J.; Khuda-Bukhsh A.R.; Relative efficacies of insulin and poly (lactic-co-glycolic) acid encapsulated nano-insulin in modulating certain significant biomarkers in arsenic intoxicated L6 cells. Colloids Surf B Biointerfaces 2013,109,10-19","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00125-016-3927-2","volume":"59","author":"Rayanagoudar G.","year":"2016","unstructured":"Rayanagoudar G.; Hashi A.A.; Zamora J.; Khan K.S.; Hitman G.A.; Thangaratinam S.; Quantification of the type 2 diabetes risk in women with gestational diabetes: A systematic review and meta-analysis of 95,750 women. Diabetologia 2016,59(7),1403-1411","journal-title":"Diabetologia"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000479874","volume":"3","author":"Su W.","year":"2017","unstructured":"Su W.; Cao R.; He Y.C.; Guan Y.F.; Ruan X.Z.; Crosstalk of hyperglycemia and dyslipidemia in diabetic kidney disease. Kidney Dis 2017,3(4),171-180","journal-title":"Kidney Dis"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2337\/diabetes.48.5.937","volume":"48","author":"Laakso M.","year":"1999","unstructured":"Laakso M.; Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 1999,48(5),937-942","journal-title":"Diabetes"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e01577","DOI":"10.1002\/brb3.1577","volume":"10","author":"Madhusudhanan J.","year":"2020","unstructured":"Madhusudhanan J.; Suresh G.; Devanathan V.; Neurodegeneration in type 2 diabetes: Alzheimer\u2019s as a case study. Brain Behav 2020,10(5),e01577","journal-title":"Brain Behav"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"5695","DOI":"10.3390\/ijms22115695","volume":"22","author":"Morais T.","year":"2021","unstructured":"Morais T.; Seabra A.L.; Patr\u00edcio B.G.; Guimar\u00e3es M.; Nora M.; Oliveira P.F.; Alves M.G.; Monteiro M.P.; Visceral adipose tissue displays unique metabolomic fingerprints in obesity, pre-diabetes and type 2 diabetes. Int J Mol Sci 2021,22(11),5695","journal-title":"Int J Mol Sci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s42255-018-0021-8","volume":"1","author":"Chouchani E.T.","year":"2019","unstructured":"Chouchani E.T.; Kajimura S.; Metabolic adaptation and maladaptation in adipose tissue. Nat Metab 2019,1(2),189-200","journal-title":"Nat Metab"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.2337\/diab.25.12.1154","volume":"25","author":"Olefsky J.M.","year":"1976","unstructured":"Olefsky J.M.; The insulin receptor: its role in insulin resistance of obesity and diabetes. Diabetes 1976,25(12),1154-1161","journal-title":"Diabetes"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1113\/expphysiol.1997.sp004038","volume":"82","author":"Sobrevia L.","year":"1997","unstructured":"Sobrevia L.; Mann G.E.; Dysfunction of the endothelial nitric oxide signalling pathway in diabetes and hyperglycaemia. Exp Physiol 1997,82(3),423-452","journal-title":"Exp Physiol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"8590","DOI":"10.3390\/ijms22168590","volume":"22","author":"Khalid M.","year":"2021","unstructured":"Khalid M.; Alkaabi J.; Khan M.A.B.; Adem A.; Insulin signal transduction perturbations in insulin resistance. Int J Mol Sci 2021,22(16),8590","journal-title":"Int J Mol Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/dmrr.648","volume":"22","author":"Svensson M.","year":"2006","unstructured":"Svensson M.; Eriksson J.W.; Insulin resistance in diabetic nephropathy - cause or consequence? Diabetes Metab Res Rev 2006,22(5),401-410","journal-title":"Diabetes Metab Res Rev"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.2337\/db09-1503","volume":"59","author":"Bostr\u00f6m P.","year":"2010","unstructured":"Bostr\u00f6m P.; Andersson L.; Vind B.; H\u00e5versen L.; Rutberg M.; Wickstr\u00f6m Y.; Larsson E.; Jansson P.A.; Svensson M.K.; Br\u00e5nemark R.; Ling C.; Beck-Nielsen H.; Bor\u00e9n J.; H\u00f8jlund K.; Olofsson S.O.; The SNARE protein SNAP23 and the SNARE-interacting protein Munc18c in human skeletal muscle are implicated in insulin resistance\/type 2 diabetes. Diabetes 2010,59(8),1870-1878","journal-title":"Diabetes"},{"key":"ref=18","first-page":"248","volume":"40","author":"Rezaei Farimani A.","year":"2015","unstructured":"Rezaei Farimani A.; Saidijam M.; Goodarzi M.T.; Yadegar Azari R.; Asadi S.; Zarei S.; Shabab N.; Effect of resveratrol supplementation on the SNARE proteins expression in adipose tissue of stroptozotocin-nicotinamide induced type 2 diabetic rats. Iran J Med Sci 2015,40(3),248-255","journal-title":"Iran J Med Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ejps.2011.07.012","volume":"44","author":"Samadder A.","year":"2011","unstructured":"Samadder A.; Chakraborty D.; De A.; Bhattacharyya S.S.; Bhadra K.; Khuda-Bukhsh A.R.; Possible signaling cascades involved in attenuation of alloxan-induced oxidative stress and hyperglycemia in mice by ethanolic extract of Syzygium jambolanum: Drug-DNA interaction with calf thymus DNA as target. Eur J Pharm Sci 2011,44(3),207-217","journal-title":"Eur J Pharm Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"R18","DOI":"10.1186\/cc7717","volume":"13","author":"Esper A.M.","year":"2009","unstructured":"Esper A.M.; Moss M.; Martin G.S.; The effect of diabetes mellitus on organ dysfunction with sepsis: an epidemiological study. Crit Care 2009,13(1),R18","journal-title":"Crit Care"},{"key":"ref=21","first-page":"590","volume":"111","author":"Oschatz E.","year":"1999","unstructured":"Oschatz E.; M\u00fcllner M.; Herkner H.; Laggner A.N.; Multiple organ failure and prognosis in adult patients with diabetic ketoacidosis. Wien Klin Wochenschr 1999,111(15),590-595","journal-title":"Wien Klin Wochenschr"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2215\/CJN.01381005","volume":"1","author":"Keane W.F.","year":"2006","unstructured":"Keane W.F.; Zhang Z.; Lyle P.A.; Cooper M.E.; de Zeeuw D.; Grunfeld J.P.; Lash J.P.; McGill J.B.; Mitch W.E.; Remuzzi G.; Shahinfar S.; Snapinn S.M.; Toto R.; Brenner B.M.; Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: The RENAAL study. Clin J Am Soc Nephrol 2006,1(4),761-767","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2337\/diacare.28.1.164","volume":"28","author":"Gross J.L.","year":"2005","unstructured":"Gross J.L.; de Azevedo M.J.; Silveiro S.P.; Canani L.H.; Caramori M.L.; Zelmanovitz T.; Diabetic nephropathy: Diagnosis, prevention, and treatment. Diabetes Care 2005,28(1),164-176","journal-title":"Diabetes Care"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1053\/j.ajkd.2017.10.026","volume":"71","author":"Umanath K.","year":"2018","unstructured":"Umanath K.; Lewis J.B.; Update on diabetic nephropathy: Core curriculum 2018. Am J Kidney Dis 2018,71(6),884-895","journal-title":"Am J Kidney Dis"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/1497449","volume":"2021","author":"Samsu N.","year":"2021","unstructured":"Samsu N.; Diabetic nephropathy: Challenges in pathogenesis, diagnosis, and treatment. BioMed Res Int 2021,2021,1-17","journal-title":"BioMed Res Int"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"CD006257","DOI":"10.1002\/14651858.CD006257","volume":"2006","author":"Strippoli G.F.M.","year":"2006","unstructured":"Strippoli G.F.M.; Bonifati C.; Craig M.E.; Navaneethan S.D.; Craig J.C.; Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Libr 2006,2006(4),CD006257","journal-title":"Cochrane Libr"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1172\/JCI112528","volume":"77","author":"Anderson S.","year":"1986","unstructured":"Anderson S.; Rennke H.G.; Brenner B.M.; Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986,77(6),1993-2000","journal-title":"J Clin Invest"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.tplants.2016.08.002","volume":"22","author":"Mittler R.","year":"2017","unstructured":"Mittler R.; ROS are good. Trends Plant Sci 2017,22(1),11-19","journal-title":"Trends Plant Sci"},{"key":"ref=29","author":"David L.","year":"2008","unstructured":"David L.; Nelson D.L.; Cox M.M.; Stiedemann L.; McGlynn M.E.; Fay M.R.; Lehninger principles of biochemistry 2008","journal-title":"Lehninger principles of biochemistry"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/4350965","volume":"2016","author":"Zhang J.","year":"2016","unstructured":"Zhang J.; Wang X.; Vikash V.; Ye Q.; Wu D.; Liu Y.; Dong W.; ROS and ROS-mediated cellular signaling. Oxid Med Cell Longev 2016,2016,1-18","journal-title":"Oxid Med Cell Longev"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1089\/ars.2007.1993","volume":"11","author":"Mart\u00ednez M.C.","year":"2009","unstructured":"Mart\u00ednez M.C.; Andriantsitohaina R.; Reactive nitrogen species: Molecular mechanisms and potential significance in health and disease. Antioxid Redox Signal 2009,11(3),669-702","journal-title":"Antioxid Redox Signal"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1189\/jlb.1012544","volume":"94","author":"Dupr\u00e9-Crochet S.","year":"2013","unstructured":"Dupr\u00e9-Crochet S.; Erard M.; N\u00fc\u03b2e, O. ROS production in phagocytes: Why, when, and where? J Leukoc Biol 2013,94(4),657-670","journal-title":"J Leukoc Biol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"w13659","DOI":"10.4414\/smw.2012.13659","volume":"142","author":"Brieger K.","year":"2012","unstructured":"Brieger K.; Schiavone S.; Miller J.; Krause K.H.; Reactive oxygen species: From health to disease. Swiss Med Wkly 2012,142,w13659","journal-title":"Swiss Med Wkly"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1383-5742(97)00041-0","volume":"410","author":"M\u00f8ller P.","year":"1998","unstructured":"M\u00f8ller P.; Wallin H.; Adduct formation, mutagenesis and nucleotide excision repair of DNA damage produced by reactive oxygen species and lipid peroxidation product. Mutat Res Rev Mutat Res 1998,410(3),271-290","journal-title":"Mutat Res Rev Mutat Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/cbf.1578","volume":"27","author":"Yajima D.","year":"2009","unstructured":"Yajima D.; Motani H.; Hayakawa M.; Sato Y.; Sato K.; Iwase H.; The relationship between cell membrane damage and lipid peroxidation under the condition of hypoxia-reoxygenation: Analysis of the mechanism using antioxidants and electron transport inhibitors. Cell Biochem 2009,27(6),338-343","journal-title":"Cell Biochem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"8722","DOI":"10.3390\/ijms13078722","volume":"13","author":"Lin T.K.","year":"2012","unstructured":"Lin T.K.; Cheng C.H.; Chen S.D.; Liou C.W.; Huang C.R.; Chuang Y.C.; Mitochondrial dysfunction and oxidative stress promote apoptotic cell death in the striatum via cytochrome c\/caspase-3 signaling cascade following chronic rotenone intoxication in rats. Int J Mol Sci 2012,13(7),8722-8739","journal-title":"Int J Mol Sci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1161\/01.ATV.0000178993.13222.f2","volume":"25","author":"Kobayashi N.","year":"2005","unstructured":"Kobayashi N.; DeLano F.A.; Schmid-Sch\u00f6nbein G.W.; Oxidative stress promotes endothelial cell apoptosis and loss of microvessels in the spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 2005,25(10),2114-2121","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"4256","DOI":"10.2174\/092986710793348581","volume":"17","author":"Kashihara N.","year":"2010","unstructured":"Kashihara N.; Haruna Y.; Kondeti V.K.; Kanwar Y.S.; Oxidative stress in diabetic nephropathy. Curr Med Chem 2010,17(34),4256-4269","journal-title":"Curr Med Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.semnephrol.2007.01.006","volume":"27","author":"Tan A.L.Y.","year":"2007","unstructured":"Tan A.L.Y.; Forbes J.M.; Cooper M.E.; AGE, RAGE, and ROS in diabetic nephropathy. Semin Nephrol 2007,27(2),130-143","journal-title":"Semin Nephrol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"F645","DOI":"10.1152\/ajprenal.00398.2004","volume":"289","author":"Bohlender J.M.","year":"2005","unstructured":"Bohlender J.M.; Franke S.; Stein G.; Wolf G.; Advanced glycation end products and the kidney. Am J Physiol Renal Physiol 2005,289(4),F645-F659","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1161\/01.CIR.101.22.2618","volume":"101","author":"Ho F.M.","year":"2000","unstructured":"Ho F.M.; Liu S.H.; Liau C.S.; Huang P.J.; Lin-Shiau S.Y.; High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3. Circulation 2000,101(22),2618-2624","journal-title":"Circulation"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"11233","DOI":"10.1073\/pnas.94.21.11233","volume":"94","author":"Konishi H.","year":"1997","unstructured":"Konishi H.; Tanaka M.; Takemura Y.; Matsuzaki H.; Ono Y.; Kikkawa U.; Nishizuka Y.; Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc Natl Acad Sci 1997,94(21),11233-11237","journal-title":"Proc Natl Acad Sci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/ki.1996.247","volume":"49","author":"Burg M.B.","year":"1996","unstructured":"Burg M.B.; Coordinate regulation of organic osmolytes in renal cells. Kidney Int 1996,49(6),1684-1685","journal-title":"Kidney Int"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1046\/j.1523-1755.1999.00382.x","volume":"55","author":"Burger-Kentischer A.","year":"1999","unstructured":"Burger-Kentischer A.; M\u00fcller E.; M\u00e4rz J.; Fraek M.L.; Thurau K.; Beck F.X.; Hypertonicity-induced accumulation of organic osmolytes in papillary interstitial cells. Kidney Int 1999,55(4),1417-1425","journal-title":"Kidney Int"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"S233","DOI":"10.1097\/01.ASN.0000077408.15865.06","volume":"14","author":"Chung S.S.M.","year":"2003","unstructured":"Chung S.S.M.; Ho E.C.M.; Lam K.S.L.; Chung S.K.; Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 2003,14(8)(Suppl. 3),S233-S236","journal-title":"J Am Soc Nephrol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1210\/jc.82.7.2294","volume":"82","author":"Shah V.O.","year":"1997","unstructured":"Shah V.O.; Dorin R.I.; Sun Y.; Braun M.; Zager P.G.; Aldose reductase gene expression is increased in diabetic nephropathy. J Clin Endocrinol Metab 1997,82(7),2294-2298","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2337\/diab.42.6.801","volume":"42","author":"Williamson J.R.","year":"1993","unstructured":"Williamson J.R.; Chang K.; Frangos M.; Hasan K.S.; Ido Y.; Kawamura T.; Nyengaard J.R.; Den Enden M.; Kilo C.; Tilton R.G.; Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 1993,42(6),801-813","journal-title":"Diabetes"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3109\/03008207.2012.754886","volume":"54","author":"Cheng X.","year":"2013","unstructured":"Cheng X.; Ni B.; Zhang Z.; Liu Q.; Wang L.; Ding Y.; Hu Y.; Polyol pathway mediates enhanced degradation of extracellular matrix via p38 MAPK activation in intervertebral disc of diabetic rats. Connect Tissue Res 2013,54(2),118-122","journal-title":"Connect Tissue Res"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1046\/j.1523-1755.2000.07702.x","volume":"58","author":"Dunlop M.","year":"2000","unstructured":"Dunlop M.; Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int 2000,58,S3-S12","journal-title":"Kidney Int"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3390\/ijms22031031","volume":"22","author":"Niimi N.","year":"2021","unstructured":"Niimi N.; Yako H.; Takaku S.; Chung S.K.; Sango K.; Aldose reductase and the polyol pathway in schwann cells: Old and new problems. Int J Mol Sci 2021,22(3),1031","journal-title":"Int J Mol Sci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0006-291X(02)02856-5","volume":"300","author":"Zill H.","year":"2003","unstructured":"Zill H.; Bek S.; Hofmann T.; Huber J.; Frank O.; Lindenmeier M.; Weigle B.; Erbersdobler H.F.; Scheidler S.; Busch A.E.; Faist V.; RAGE-mediated MAPK activation by food-derived AGE and non-AGE products. Biochem Biophys Res Commun 2003,300(2),311-315","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/dmrr.2560","volume":"31","author":"Hu H.","year":"2015","unstructured":"Hu H.; Jiang H.; Ren H.; Hu X.; Wang X.; Han C.; AGEs and chronic subclinical inflammation in diabetes: Disorders of immune system. Diabetes Metab Res Rev 2015,31(2),127-137","journal-title":"Diabetes Metab Res Rev"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.phrs.2016.11.004","volume":"114","author":"Qiu Y.","year":"2016","unstructured":"Qiu Y.; Tang L.; Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy. Pharmacol Res 2016,114,251-264","journal-title":"Pharmacol Res"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41419-020-2598-6","volume":"11","author":"Wang J.","year":"2020","unstructured":"Wang J.; Shen X.; Liu J.; Chen W.; Wu F.; Wu W.; Meng Z.; Zhu M.; Miao C.; High glucose mediates NLRP3 inflammasome activation via upregulation of ELF3 expression. Cell Death Dis 2020,11(5),383","journal-title":"Cell Death Dis"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"a016287","DOI":"10.1101\/cshperspect.a016287","volume":"6","author":"de Zoete M.R.","year":"2014","unstructured":"de Zoete M.R.; Palm N.W.; Zhu S.; Flavell R.A.; Inflammasomes. Cold Spring Harb Perspect Biol 2014,6(12),a016287","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"e56316","DOI":"10.1371\/journal.pone.0056316","volume":"8","author":"M\u00fcller R.","year":"2013","unstructured":"M\u00fcller R.; Daniel C.; Hugo C.; Amann K.; Mielenz D.; Endlich K.; Braun T.; van der Veen B.; Heeringa P.; Schett G.; Zwerina J.; The mitogen-activated protein kinase p38and#945; regulates tubular damage in murine anti-glomerular basement membrane nephritis. PLoS One 2013,8(2),e56316","journal-title":"PLoS One"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1681\/ASN.2007091048","volume":"19","author":"Navarro-Gonz\u00e1lez J.F.","year":"2008","unstructured":"Navarro-Gonz\u00e1lez J.F.; Mora-Fern\u00e1ndez C.; The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 2008,19(3),433-442","journal-title":"J Am Soc Nephrol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"32926","DOI":"10.1074\/jbc.M114.579961","volume":"289","author":"Okada M.","year":"2014","unstructured":"Okada M.; Matsuzawa A.; Yoshimura A.; Ichijo H.; The lysosome rupture-activated TAK1-JNK pathway regulates NLRP3 inflammasome activation. J Biol Chem 2014,289(47),32926-32936","journal-title":"J Biol Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1016\/j.biocel.2008.06.012","volume":"40","author":"Yang R.","year":"2008","unstructured":"Yang R.; Trevillyan J.M.; c-Jun N-terminal kinase pathways in diabetes. Int J Biochem Cell Biol 2008,40(12),2702-2706","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3389\/fphys.2014.00352","volume":"5","author":"Harijith A.","year":"2014","unstructured":"Harijith A.; Ebenezer D.L.; Natarajan V.; Reactive oxygen species at the crossroads of inflammasome and inflammation. Front Physiol 2014,5,352","journal-title":"Front Physiol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bbrc.2016.11.017","volume":"481","author":"Sun X.","year":"2016","unstructured":"Sun X.; Jiao X.; Ma Y.; Liu Y.; Zhang L.; He Y.; Chen Y.; Trimethylamine N-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ROS-TXNIP-NLRP3 inflammasome. Biochem Biophys Res Commun 2016,481(1-2),63-70","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1369\/0022155412465073","volume":"60","author":"Kolset S.O.","year":"2012","unstructured":"Kolset S.O.; Reinholt F.P.; Jenssen T.; Diabetic nephropathy and extracellular matrix. J Histochem Cytochem 2012,60(12),976-986","journal-title":"J Histochem Cytochem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1046\/j.1523-1755.2001.00493.x","volume":"59","author":"Moriya T.","year":"2001","unstructured":"Moriya T.; Groppoli T.J.; Kim Y.; Mauer M.; Quantitative immunoelectron microscopy of type VI collagen in glomeruli in type I diabetic patients. Kidney Int 2001,59(1),317-323","journal-title":"Kidney Int"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1159\/000052614","volume":"9","author":"Yard B.A.","year":"2001","unstructured":"Yard B.A.; Kahlert S.; Engelleiter R.; Resch S.; Waldherr R.; Groffen A.J.; van den Heuvel L.P.W.J.; van der Born J.; Berden J.H.M.; Kr\u00f6ger S.; Hafner M.; van der Woude F.J.; Decreased glomerular expression of agrin in diabetic nephropathy and podocytes, cultured in high glucose medium. Nephron, Exp Nephrol 2001,9(3),214-222","journal-title":"Nephron, Exp Nephrol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1080\/00365590802502111","volume":"43","author":"Holmquist P.","year":"2009","unstructured":"Holmquist P.; Torffvit O.; Urinary transforming growth factor-\u03b2 1, collagen IV and the effect of insulin in children at diagnosis of diabetes mellitus. Scand J Urol Nephrol 2009,43(2),142-147","journal-title":"Scand J Urol Nephrol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1046\/j.1523-1755.2000.00868.x","volume":"57","author":"Stokes M.B.","year":"2000","unstructured":"Stokes M.B.; Holler S.; Cui Y.; Hudkins K.L.; Eitner F.; Fogo A.; Alpers C.E.; Expression of decorin, biglycan, and collagen type I in human renal fibrosing disease. Kidney Int 2000,57(2),487-498","journal-title":"Kidney Int"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1196\/annals.1333.089","volume":"1043","author":"Figarola J.L.","year":"2005","unstructured":"Figarola J.L.; Scott S.; Loera S.; Xi B.; Synold T.; Rahbar S.; Renoprotective and lipid-lowering effects of LR compounds, novel advanced glycation end product inhibitors, in streptozotocin-induced diabetic rats. Ann N Y Acad Sci 2005,1043(1),767-776","journal-title":"Ann N Y Acad Sci"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2174\/1570161115666170202162345","volume":"15","author":"Dimas G.G.","year":"2017","unstructured":"Dimas G.G.; Didangelos T.P.; Grekas D.M.; Matrix gelatinases in atherosclerosis and diabetic nephropathy: progress and challenges. Curr Vasc Pharmacol 2017,15(6),557-565","journal-title":"Curr Vasc Pharmacol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/125469","volume":"2013","author":"Srivastava S.P.","year":"2013","unstructured":"Srivastava S.P.; Koya D.; Kanasaki K.; MicroRNAs in kidney fibrosis and diabetic nephropathy: Roles on EMT and EndMT. BioMed Res Int 2013,2013,1-10","journal-title":"BioMed Res Int"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"F1060","DOI":"10.1152\/ajprenal.00191.2002","volume":"285","author":"Zeisberg M.","year":"2003","unstructured":"Zeisberg M.; Bottiglio C.; Kumar N.; Maeshima Y.; Strutz F.; M\u00fcller G.A.; Kalluri R.; Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol 2003,285(6),F1060-F1067","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"Kalluri R.","year":"2009","unstructured":"Kalluri R.; Weinberg R.A.; The basics of epithelial-mesenchymal transition. J Clin Invest 2009,119(6),1420-1428","journal-title":"J Clin Invest"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.2353\/ajpath.2010.090188","volume":"176","author":"Tan T.K.","year":"2010","unstructured":"Tan T.K.; Zheng G.; Hsu T.T.; Wang Y.; Lee V.W.S.; Tian X.; Wang Y.; Cao Q.; Wang Y.; Harris D.C.H.; Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells. Am J Pathol 2010,176(3),1256-1270","journal-title":"Am J Pathol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"D98","DOI":"10.1093\/nar\/gkn714","volume":"37","author":"Jiang Q.","year":"2009","unstructured":"Jiang Q.; Wang Y.; Hao Y.; Juan L.; Teng M.; Zhang X.; Li M.; Wang G.; Liu Y.; miR2Disease: A manually curated database for microRNA deregulation in human disease. Nucleic Acids Res 2009,37(S1),D98-D104","journal-title":"Nucleic Acids Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"7846","DOI":"10.1158\/0008-5472.CAN-08-1942","volume":"68","author":"Bracken C.P.","year":"2008","unstructured":"Bracken C.P.; Gregory P.A.; Kolesnikoff N.; Bert A.G.; Wang J.; Shannon M.F.; Goodall G.J.; A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 2008,68(19),7846-7854","journal-title":"Cancer Res"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1152\/physrev.00020.2002","volume":"83","author":"Pavenst\u00e4dt H.","year":"2003","unstructured":"Pavenst\u00e4dt H.; Kriz W.; Kretzler M.; Cell biology of the glomerular podocyte. Physiol Rev 2003,83(1),253-307","journal-title":"Physiol Rev"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.yexcr.2012.02.025","volume":"318","author":"Abboud H.E.","year":"2012","unstructured":"Abboud H.E.; Mesangial cell biology. Exp Cell Res 2012,318(9),979-985","journal-title":"Exp Cell Res"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1046\/j.1523-1755.1999.00710.x","volume":"56","author":"Sch\u00f6cklmann H.O.","year":"1999","unstructured":"Sch\u00f6cklmann H.O.; Lang S.; Sterzel R.B.; Regulation of mesangial cell proliferation. Kidney Int 1999,56(4),1199-1207","journal-title":"Kidney Int"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/sj.ki.5002180","volume":"71","author":"Simonson M.S.","year":"2007","unstructured":"Simonson M.S.; Phenotypic transitions and fibrosis in diabetic nephropathy. Kidney Int 2007,71(9),846-854","journal-title":"Kidney Int"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1038\/sj.ki.5002384","volume":"72","author":"Li J.J.","year":"2007","unstructured":"Li J.J.; Kwak S.J.; Jung D.S.; Kim J.J.; Yoo T.H.; Ryu D.R.; Han S.H.; Choi H.Y.; Lee J.E.; Moon S.J.; Kim D.K.; Han D.S.; Kang S.W.; Podocyte biology in diabetic nephropathy. Kidney Int 2007,72(106),S36-S42","journal-title":"Kidney Int"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000091464","volume":"17","author":"Bai Y.","year":"2006","unstructured":"Bai Y.; Wang L.; Li Y.; Liu S.; Li J.; Wang H.; Huang H.; High ambient glucose levels modulates the production of MMP-9 and alpha5(IV) collagen by cultured podocytes. Cell Physiol Biochem 2006,17(1-2),57-68","journal-title":"Cell Physiol Biochem"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/j.1523-1755.2005.00158.x","volume":"67","author":"Xu Z.G.","year":"2005","unstructured":"Xu Z.G.; Yoo T.H.; Ryu D.R.; Park H.C.; Ha S.K.; Han D.S.; Adler S.G.; Natarajan R.; Kang S.W.; Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli. Kidney Int 2005,67(3),944-952","journal-title":"Kidney Int"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/emm.2004.9","volume":"36","author":"Lee E.Y.","year":"2004","unstructured":"Lee E.Y.; Shim M.S.; Kim M.J.; Hong S.Y.; Shin Y.G.; Chung C.H.; Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytes. Exp Mol Med 2004,36(1),65-70","journal-title":"Exp Mol Med"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.semnephrol.2012.06.010","volume":"32","author":"Tufro A.","year":"2012","unstructured":"Tufro A.; Veron D.; VEGF and podocytes in diabetic nephropathy. Semin Nephrol 2012,32(4),385-393","journal-title":"Semin Nephrol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ki.2010.64","volume":"77","author":"Veron D.","year":"2010","unstructured":"Veron D.; Reidy K.; Bertuccio C.; Techman J.; Villegas G.; Jimenez J.; Shen W.; Kopp J.; Thomas D.; Tufro A.; Induction of podocyte VEGF-A overexpression in adult mice causes glomerular disease. Kidney Int 2010,77,989-999","journal-title":"Kidney Int"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.ajpath.2011.06.033","volume":"179","author":"Nijenhuis T.","year":"2011","unstructured":"Nijenhuis T.; Sloan A.J.; Hoenderop J.G.J.; Flesche J.; van Goor H.; Kistler A.D.; Bakker M.; Bindels R.J.M.; de Boer R.A.; M\u00f6ller C.C.; Hamming I.; Navis G.; Wetzels J.F.M.; Berden J.H.M.; Reiser J.; Faul C.; van der Vlag J.; Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Am J Pathol 2011,179(4),1719-1732","journal-title":"Am J Pathol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1681\/ASN.2005121355","volume":"17","author":"Lin C.L.","year":"2006","unstructured":"Lin C.L.; Wang J.Y.; Huang Y.T.; Kuo Y.H.; Surendran K.; Wang F.S.; Wnt\/beta-catenin signaling modulates survival of high glucose-stressed mesangial cells. J Am Soc Nephrol 2006,17(10),2812-2820","journal-title":"J Am Soc Nephrol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1681\/ASN.2008101059","volume":"21","author":"Lin C.L.","year":"2010","unstructured":"Lin C.L.; Wang J.Y.; Ko J.Y.; Huang Y.T.; Kuo Y.H.; Wang F.S.; Dickkopf-1 promotes hyperglycemia-induced accumulation of mesangial matrix and renal dysfunction. J Am Soc Nephrol 2010,21(1),124-135","journal-title":"J Am Soc Nephrol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/nep.13451","volume":"23","author":"Tung C.W.","year":"2018","unstructured":"Tung C.W.; Hsu Y.C.; Shih Y.H.; Chang P.J.; Lin C.L.; Glomerular mesangial cell and podocyte injuries in diabetic nephropathy. Nephrology (Carlton) 2018,23(S4),32-37","journal-title":"Nephrology (Carlton)"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1210\/en.2007-1372","volume":"149","author":"Lin C.L.","year":"2008","unstructured":"Lin C.L.; Wang J.Y.; Ko J.Y.; Surendran K.; Huang Y.T.; Kuo Y.H.; Wang F.S.; Superoxide destabilization of beta-catenin augments apoptosis of high-glucose-stressed mesangial cells. Endocrinology 2008,149(6),2934-2942","journal-title":"Endocrinology"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1161\/CIRCGENETICS.115.001138","volume":"8","author":"Wang F.","year":"2015","unstructured":"Wang F.; Fisher S.A.; Zhong J.; Wu Y.; Yang P.; Superoxide dismutase 1 in vivo ameliorates maternal diabetes mellitus-induced apoptosis and heart defects through restoration of impaired Wnt signaling. Circ Cardiovasc Genet 2015,8(5),665-676","journal-title":"Circ Cardiovasc Genet"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1681\/ASN.2013050527","volume":"25","author":"Lin C.L.","year":"2014","unstructured":"Lin C.L.; Lee P.H.; Hsu Y.C.; Lei C.C.; Ko J.Y.; Chuang P.C.; Huang Y.T.; Wang S.Y.; Wu S.L.; Chen Y.S.; Chiang W.C.; Reiser J.; Wang F.S.; MicroRNA-29a promotion of nephrin acetylation ameliorates hyperglycemia-induced podocyte dysfunction. J Am Soc Nephrol 2014,25(8),1698-1709","journal-title":"J Am Soc Nephrol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1681\/ASN.2014040405","volume":"26","author":"Li X.","year":"2015","unstructured":"Li X.; Chuang P.Y.; D\u2019Agati V.D.; Dai Y.; Yacoub R.; Fu J.; Xu J.; Taku O.; Premsrirut P.K.; Holzman L.B.; He J.C.; Nephrin preserves podocyte viability and glomerular structure and function in adult kidneys. J Am Soc Nephrol 2015,26(10),2361-2377","journal-title":"J Am Soc Nephrol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nm1731","volume":"14","author":"Niranjan T.","year":"2008","unstructured":"Niranjan T.; Bielesz B.; Gruenwald A.; Ponda M.P.; Kopp J.B.; Thomas D.B.; Susztak K.; The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 2008,14(3),290-298","journal-title":"Nat Med"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2174\/1573399052952622","volume":"1","author":"Gruden G.","year":"2005","unstructured":"Gruden G.; Perin P.; Camussi G.; Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology. Curr Diabetes Rev 2005,1(1),27-40","journal-title":"Curr Diabetes Rev"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"F671","DOI":"10.1152\/ajprenal.00266.2002","volume":"284","author":"Kitsiou P.V.","year":"2003","unstructured":"Kitsiou P.V.; Tzinia A.K.; Stetler-Stevenson W.G.; Michael A.F.; Fan W.W.; Zhou B.; Tsilibary E.C.; Glucose-induced changes in integrins and matrix-related functions in cultured human glomerular epithelial cells. Am J Physiol Renal Physiol 2003,284(4),F671-F679","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fj.02-0125fje","volume":"16","author":"Endlich N.","year":"2002","unstructured":"Endlich N.; Sunohara M.; Nietfeld W.; Wolski E.W.; Schiwek D.; Kr\u00e4Nzlin, B.; Gretz, N.; Kriz, W.; Eickhoff, H.; Endlich, K. Analysis of differential gene expression in stretched podocytes: osteopontin enhances adaptation of podocytes to mechanical stress. FASEB J 2002,16(13),1-24","journal-title":"FASEB J"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1681\/ASN.V123413","volume":"12","author":"Endlich N.","year":"2001","unstructured":"Endlich N.; Kress K.R.; Reiser J.; Uttenweiler D.; Kriz W.; Mundel P.; Endlich K.; Podocytes respond to mechanical stress in vitro. J Am Soc Nephrol 2001,12(3),413-422","journal-title":"J Am Soc Nephrol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1517\/17460441.2013.837883","volume":"8","author":"Safavi M.","year":"2013","unstructured":"Safavi M.; Foroumadi A.; Abdollahi M.; The importance of synthetic drugs for type 2 diabetes drug discovery. Expert Opin Drug Discov 2013,8(11),1339-1363","journal-title":"Expert Opin Drug Discov"},{"key":"ref=99","author":"Eggleton J.S.","year":"2021","unstructured":"Eggleton J.S.; Jialal I.; Thiazolidinediones. StatPearls 2021","journal-title":"StatPearls"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1056\/NEJMra041001","volume":"351","author":"Yki-J\u00e4rvinen H.","year":"2004","unstructured":"Yki-J\u00e4rvinen H.; Thiazolidinediones. N Engl J Med 2004,351(11),1106-1118","journal-title":"N Engl J Med"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","volume":"60","author":"Rena G.","year":"2017","unstructured":"Rena G.; Hardie D.G.; Pearson E.R.; The mechanisms of action of metformin. Diabetologia 2017,60(9),1577-1585","journal-title":"Diabetologia"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.cmet.2010.04.001","volume":"11","author":"Hawley S.A.","year":"2010","unstructured":"Hawley S.A.; Ross F.A.; Chevtzoff C.; Green K.A.; Evans A.; Fogarty S.; Towler M.C.; Brown L.J.; Ogunbayo O.A.; Evans A.M.; Hardie D.G.; Use of cells expressing \u03b3 subunit variants to identify diverse mechanisms of AMPK activation. Cell Metab 2010,11(6),554-565","journal-title":"Cell Metab"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.2337\/diab.40.10.1259","volume":"40","author":"Vincent M.F.","year":"1991","unstructured":"Vincent M.F.; Marangos P.J.; Gruber H.E.; van den Berghe G.; Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes. Diabetes 1991,40(10),1259-1266","journal-title":"Diabetes"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.2165\/00003495-200464120-00006","volume":"64","author":"Rendell M.","year":"2004","unstructured":"Rendell M.; The role of sulphonylureas in the management of type 2 diabetes mellitus. Drugs 2004,64(12),1339-1358","journal-title":"Drugs"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2337\/diacare.9.2.129","volume":"9","author":"Groop L.C.","year":"1986","unstructured":"Groop L.C.; Pelkonen R.; Koskimies S.; Bottazzo G.F.; Doniach D.; Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes. Diabetes Care 1986,9(2),129-133","journal-title":"Diabetes Care"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1055\/s-2007-978737","volume":"31","author":"Yildiz B.","year":"1999","unstructured":"Yildiz B.; G\u00fcrlek A.; Failure of sulfonylureas in type 2 diabetes. Horm Metab Res 1999,31(4),293-294","journal-title":"Horm Metab Res"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"936","DOI":"10.5114\/aoms.2013.34991","volume":"5","author":"Guardado-Mendoza R.","year":"2013","unstructured":"Guardado-Mendoza R.; Prioletta A.; Jim\u00e9nez-Ceja L.M.; Sosale A.; Folli F.; State of the art paper The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus. Arch Med Sci 2013,5(5),936-943","journal-title":"Arch Med Sci"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.2337\/diabetes.51.9.2789","volume":"51","author":"Hansen A.M.K.","year":"2002","unstructured":"Hansen A.M.K.; Christensen I.T.; Hansen J.B.; Carr R.D.; Ashcroft F.M.; Wahl P.; Differential interactions of nateglinide and repaglinide on the human \u03b2-cell sulphonylurea receptor 1. Diabetes 2002,51(9),2789-2795","journal-title":"Diabetes"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1093\/ajhp\/58.13.1200","volume":"58","author":"Halas C.J.","year":"2001","unstructured":"Halas C.J.; Nateglinide. Am J Health Syst Pharm 2001,58(13),1200-1205","journal-title":"Am J Health Syst Pharm"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJM199601043340103","volume":"334","author":"Klag M.J.","year":"1996","unstructured":"Klag M.J.; Whelton P.K.; Randall B.L.; Neaton J.D.; Brancati F.L.; Ford C.E.; Shulman N.B.; Stamler J.; Blood pressure and end-stage renal disease in men. N Engl J Med 1996,334(1),13-18","journal-title":"N Engl J Med"},{"key":"ref=111","doi-asserted-by":"crossref","first-page":"24","DOI":"10.47102\/annals-acadmedsg.V34N1p24","volume":"34","author":"Lee G.S.","year":"2005","unstructured":"Lee G.S.; Retarding the progression of diabetic nephropathy in type 2 diabetes mellitus: Focus on hypertension and proteinuria. Ann Acad Med Singap 2005,34(1),24-30","journal-title":"Ann Acad Med Singap"},{"key":"ref=112","first-page":"29","volume":"8","author":"Yacoub R.","year":"2015","unstructured":"Yacoub R.; Campbell K.N.; Inhibition of RAS in diabetic nephropathy. Int J Nephrol Renovasc Dis 2015,8,29-40","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0272-6386(00)70018-7","volume":"35","author":"Kshirsagar A.V.","year":"2000","unstructured":"Kshirsagar A.V.; Joy M.S.; Hogan S.L.; Falk R.J.; Colindres R.E.; Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: A systematic overview of randomized placebo-controlled trials. Am J Kidney Dis 2000,35(4),695-707","journal-title":"Am J Kidney Dis"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2174\/157339913804143207","volume":"9","author":"Noel Van Buren P.","year":"2013","unstructured":"Noel Van Buren P.; Toto R.; Current update in the management of diabetic nephropathy. Curr Diabetes Rev 2013,9(1),62-77","journal-title":"Curr Diabetes Rev"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1681\/ASN.2010101049","volume":"22","author":"Sharma K.","year":"2011","unstructured":"Sharma K.; Ix J.H.; Mathew A.V.; Cho M.; Pflueger A.; Dunn S.R.; Francos B.; Sharma S.; Falkner B.; McGowan T.A.; Donohue M.; RamachandraRao, S.; Xu, R.; Fervenza, F.C.; Kopp, J.B. Pirfenidone for diabetic nephropathy. J Am Soc Nephrol 2011,22(6),1144-1151","journal-title":"J Am Soc Nephrol"},{"key":"ref=116","first-page":"6275","volume":"9","author":"Li R.","year":"2015","unstructured":"Li R.; Xing J.; Mu X.; Wang H.; Zhang L.; Zhao Y.; Zhang Y.; Sulodexide therapy for the treatment of diabetic nephropathy, a meta-analysis and literature review. Drug Des Devel Ther 2015,9,6275-6283","journal-title":"Drug Des Devel Ther"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1159\/000064071","volume":"92","author":"Soma J.","year":"2002","unstructured":"Soma J.; Sugawara T.; Huang Y.D.; Nakajima J.; Kawamura M.; Tranilast slows the progression of advanced diabetic nephropathy. Nephron J 2002,92(3),693-698","journal-title":"Nephron J"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.2337\/diacare.28.11.2686","volume":"28","author":"Tuttle K.R.","year":"2005","unstructured":"Tuttle K.R.; Bakris G.L.; Toto R.D.; McGill J.B.; Hu K.; Anderson P.W.; The effect of ruboxistaurin on nephropathy in type 2 diabetes. Diabetes Care 2005,28(11),2686-2690","journal-title":"Diabetes Care"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1681\/ASN.2011111097","volume":"23","author":"Chen J.L.T.","year":"2012","unstructured":"Chen J.L.T.; Francis J.; Pyridoxamine, advanced glycation inhibition, and diabetic nephropathy. J Am Soc Nephrol 2012,23(1),6-8","journal-title":"J Am Soc Nephrol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s10157-020-01917-5","volume":"24","author":"Kanda H.","year":"2020","unstructured":"Kanda H.; Yamawaki K.; Bardoxolone methyl: drug development for diabetic kidney disease. Clin Exp Nephrol 2020,24(10),857-864","journal-title":"Clin Exp Nephrol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1194\/jlr.P040501","volume":"55","author":"Herman-Edelstein M.","year":"2014","unstructured":"Herman-Edelstein M.; Scherzer P.; Tobar A.; Levi M.; Gafter U.; Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy. J Lipid Res 2014,55(3),561-572","journal-title":"J Lipid Res"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"e105787","DOI":"10.1371\/journal.pone.0105787","volume":"9","author":"Tsun J.G.S.","year":"2014","unstructured":"Tsun J.G.S.; Yung S.; Chau M.K.M.; Shiu S.W.M.; Chan T.M.; Tan K.C.B.; Cellular cholesterol transport proteins in diabetic nephropathy. PLoS One 2014,9(9),e105787","journal-title":"PLoS One"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1093\/ndt\/13.6.1391","volume":"13","author":"Ruan X.","year":"1998","unstructured":"Ruan X.; Varghese Z.; Fernando R.; Moorhead J.F.; Cytokines regulation of low-density lipoprotein receptor gene transcription in human mesangial cells. Nephrol Dial Transplant 1998,13(6),1391-1397","journal-title":"Nephrol Dial Transplant"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/01.ASN.0000050414.52908.DA","volume":"14","author":"Ruan X.Z.","year":"2003","unstructured":"Ruan X.Z.; Moorhead J.F.; Fernando R.; Wheeler D.C.; Powis S.H.; Varghese Z.; PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. J Am Soc Nephrol 2003,14(3),593-600","journal-title":"J Am Soc Nephrol"},{"key":"ref=125","first-page":"803","author":"Ling L.J.","year":"1996","unstructured":"Ling L.J.; Calcium channel blockers. Emergency Medicine: A Comprehensive Study Guide 1996,803-805","journal-title":"Emergency Medicine: A Comprehensive Study Guide"},{"key":"ref=126","first-page":"155","volume":"9","author":"Lip G.Y.H.","year":"1995","unstructured":"Lip G.Y.H.; Ferner R.E.; Poisoning with anti-hypertensive drugs: Calcium antagonists. J Hum Hypertens 1995,9(3),155-161","journal-title":"J Hum Hypertens"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0735-6757(98)90011-0","volume":"16","author":"Adams B.D.","year":"1998","unstructured":"Adams B.D.; Browne W.T.; Amlodipine overdose causes prolonged calcium channel blocker toxicity. Am J Emerg Med 1998,16(5),527-528","journal-title":"Am J Emerg Med"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1080\/00365520600761676","volume":"41","author":"Eland I.A.","year":"2006","unstructured":"Eland I.A.; Sundstr\u00f6m A.; Velo G.P.; Andersen M.; Sturkenboom M.C.J.M.; Langman M.J.S.; Stricker B.H.C.H.; Wiholm B.; Eland I.A.; Sundstr\u00f6m A.; Velo G.P.; Andersen M.; Sturkenboom M.C.J.M.; Langman M.J.S.; Stricker B.H.C.H.; Wiholm B.; Antihypertensive medication and the risk of acute pancreatitis: The European case-control study on drug-induced acute pancreatitis (EDIP). Scand J Gastroenterol 2006,41(12),1484-1490","journal-title":"Scand J Gastroenterol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/j.1471-0528.2004.00525.x","volume":"112","author":"Serreau R.","year":"2005","unstructured":"Serreau R.; Luton D.; Macher M.A.; Delezoide A.L.; Garel C.; Jacqz-Aigrain E.; Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: A report of 10 cases. BJOG 2005,112(6),710-712","journal-title":"BJOG"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0368-2315(06)76471-7","volume":"35","author":"Payen V.","year":"2006","unstructured":"Payen V.; Chemin A.; Jonville-B\u00e9ra A.P.; Saliba E.; Cantagrel S.; Fetal toxicity of angiotensin-II receptor antagonists. J Gynecol Obstet Biol Reprod (Paris) 2006,35(7),729-731","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s00467-006-0162-y","volume":"21","author":"Simonetti G.D.","year":"2006","unstructured":"Simonetti G.D.; Baumann T.; Pachlopnik J.M.; von Vigier R.O.; Bianchetti M.G.; Non-lethal fetal toxicity of the angiotensin receptor blocker candesartan. Pediatr Nephrol 2006,21(9),1329-1330","journal-title":"Pediatr Nephrol"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.gyobfe.2007.03.015","volume":"35","author":"Roger N.","year":"2007","unstructured":"Roger N.; Popovic I.; Madelenat P.; Mahieu-Caputo D.; Fetal toxicity of angiotensin-II-receptor inhibitors. Case report. Gyn\u00e9col Obst\u00e9t Fertil 2007,35(6),556-560","journal-title":"Gyn\u00e9col Obst\u00e9t Fertil"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1177\/0885066618793385","volume":"34","author":"Wang G.S.","year":"2019","unstructured":"Wang G.S.; Hoyte C.; Review of biguanide (metformin) toxicity. J Intensive Care Med 2019,34(11-12),863-876","journal-title":"J Intensive Care Med"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jemermed.2007.11.055","volume":"40","author":"Perrone J.","year":"2011","unstructured":"Perrone J.; Phillips C.; Gaieski D.; Occult metformin toxicity in three patients with profound lactic acidosis. J Emerg Med 2011,40(3),271-275","journal-title":"J Emerg Med"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2174\/1574210195346398863","volume":"8","author":"Shadnia S.","year":"2013","unstructured":"Shadnia S.; Barzi F.; Askari A.; Hassanian-Moghaddam H.; Zamani N.; Ebrahimian K.; Metformin toxicity: A report of 204 cases from Iran. Curr Drug Saf 2013,8(4),278-281","journal-title":"Curr Drug Saf"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1136\/pgmj.2003.011957","volume":"80","author":"Mallick S.","year":"2004","unstructured":"Mallick S.; Metformin induced acute pancreatitis precipitated by renal failure. Postgrad Med J 2004,80(942),239-240","journal-title":"Postgrad Med J"},{"key":"ref=137","first-page":"305","volume":"27","author":"Scheen A.J.","year":"2001","unstructured":"Scheen A.J.; Thiazolidinediones and liver toxicity. Diabetes Metab 2001,27(3),305-313","journal-title":"Diabetes Metab"},{"key":"ref=138","first-page":"540","volume":"13","author":"Famularo G.","year":"2012","unstructured":"Famularo G.; Gasbarrone L.; Minisola G.; Pancreatitis during treatment with liraglutide. JOP 2012,13(5),540-541","journal-title":"JOP"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/biomedicines9020106","volume":"9","author":"Maor Y.","year":"2021","unstructured":"Maor Y.; Ergaz D.; Malnick S.D.H.; Melzer E.; Neuman M.G.; Liraglutide-induced hepatotoxicity. Biomedicines 2021,9(2),106","journal-title":"Biomedicines"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2337\/diacare.29.02.06.dc05-2043","volume":"29","author":"Denker P.S.","year":"2006","unstructured":"Denker P.S.; Dimarco P.E.; Exenatide (exendin-4)-induced pancreatitis: A case report. Diabetes Care 2006,29(2),471","journal-title":"Diabetes Care"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1517\/14740338.5.6.835","volume":"5","author":"McGill J.B.","year":"2006","unstructured":"McGill J.B.; King G.L.; Berg P.H.; Price K.L.; Kles K.A.; Bastyr E.J.; Hyslop D.L.; Clinical safety of the selective PKC-\u03b2 inhibitor, ruboxistaurin. Expert Opin Drug Saf 2006,5(6),835-845","journal-title":"Expert Opin Drug Saf"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1159\/000173253","volume":"31","author":"Waanders F.","year":"2008","unstructured":"Waanders F.; van Goor H.; Navis G.; Adverse renal effects of the AGE inhibitor pyridoxamine in combination with ACEi in non-diabetic adriamycin-induced renal damage in rats. Kidney Blood Press Res 2008,31(5),350-359","journal-title":"Kidney Blood Press Res"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.3390\/nu11102288","volume":"11","author":"Dabeek W.M.","year":"2019","unstructured":"Dabeek W.M.; Marra M.V.; Dietary quercetin and kaempferol: Bioavailability and potential cardiovascular-related bioactivity in humans. Nutrients 2019,11(10),2288","journal-title":"Nutrients"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/ptr.5518","volume":"30","author":"Lu N.T.","year":"2016","unstructured":"Lu N.T.; Crespi C.M.; Liu N.M.; Vu J.Q.; Ahmadieh Y.; Wu S.; Lin S.; McClune A.; Durazo F.; Saab S.; Han S.; Neiman D.C.; Beaven S.; French S.W.; A phase I dose escalation study demonstrates quercetin safety and explores potential for bioflavonoid antivirals in patients with chronic hepatitis C. Phytother Res 2016,30(1),160-168","journal-title":"Phytother Res"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/cancers11010038","volume":"11","author":"Vivarelli S.","year":"2019","unstructured":"Vivarelli S.; Salemi R.; Candido S.; Falzone L.; Santagati M.; Stefani S.; Torino F.; Banna G.L.; Tonini G.; Libra M.; Gut microbiota and cancer: From pathogenesis to therapy. Cancers 2019,11(1),38","journal-title":"Cancers"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"104621","DOI":"10.1016\/j.nbd.2019.104621","volume":"134","author":"Gubert C.","year":"2020","unstructured":"Gubert C.; Kong G.; Renoir T.; Hannan A.J.; Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases. Neurobiol Dis 2020,134,104621","journal-title":"Neurobiol Dis"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nn.4476","volume":"20","author":"Fung T.C.","year":"2017","unstructured":"Fung T.C.; Olson C.A.; Hsiao E.Y.; Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci 2017,20(2),145-155","journal-title":"Nat Neurosci"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1161\/CIRCRESAHA.120.316242","volume":"127","author":"Witkowski M.","year":"2020","unstructured":"Witkowski M.; Weeks T.L.; Hazen S.L.; Gut microbiota and cardiovascular disease. Circ Res 2020,127(4),553-570","journal-title":"Circ Res"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4239\/wjd.v13.i3.150","volume":"13","author":"Nagase N.","year":"2022","unstructured":"Nagase N.; Ikeda Y.; Tsuji A.; Kitagishi Y.; Matsuda S.; Efficacy of probiotics on the modulation of gut microbiota in the treatment of diabetic nephropathy. World J Diabetes 2022,13(3),150-160","journal-title":"World J Diabetes"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.2147\/DMSO.S320169","volume":"14","author":"Chen W.","year":"2021","unstructured":"Chen W.; Zhang M.; Guo Y.; Wang Z.; Liu Q.; Yan R.; Wang Y.; Wu Q.; Yuan K.; Sun W.; The profile and function of gut microbiota in diabetic nephropathy. Diabetes Metab Syndr Obes 2021,14,4283-4296","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"9641","DOI":"10.3390\/ijms22179641","volume":"22","author":"Zaky A.","year":"2021","unstructured":"Zaky A.; Glastras S.J.; Wong M.Y.W.; Pollock C.A.; Saad S.; The role of the gut microbiome in diabetes and obesity-related kidney disease. Int J Mol Sci 2021,22(17),9641","journal-title":"Int J Mol Sci"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11894-016-0494-0","volume":"18","author":"Patcharatrakul T.","year":"2016","unstructured":"Patcharatrakul T.; Gonlachanvit S.; Chili peppers, curcumins, and prebiotics in gastrointestinal health and disease. Curr Gastroenterol Rep 2016,18(4),19","journal-title":"Curr Gastroenterol Rep"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.3390\/foods10102371","volume":"10","author":"Nissen L.","year":"2021","unstructured":"Nissen L.; Valerii M.C.; Spisni E.; Casciano F.; Gianotti A.; multiunit in vitro Colon model for the evaluation of prebiotic potential of a fiber plus D- Limonene food supplement. Foods 2021,10(10),2371","journal-title":"Foods"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ijfoodmicro.2008.03.017","volume":"124","author":"Parkar S.G.","year":"2008","unstructured":"Parkar S.G.; Stevenson D.E.; Skinner M.A.; The potential influence of fruit polyphenols on colonic microflora and human gut health. Int J Food Microbiol 2008,124(3),295-298","journal-title":"Int J Food Microbiol"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3389\/fphar.2018.01181","volume":"9","author":"Zhang Z.B.","year":"2018","unstructured":"Zhang Z.B.; Luo D.D.; Xie J.H.; Xian Y.F.; Lai Z.Q.; Liu Y.H.; Liu W.H.; Chen J.N.; Lai X.P.; Lin Z.X.; Su Z.R.; Curcumin\u2019s metabolites, tetrahydrocurcumin and octahydrocurcumin, possess superior anti-inflammatory effects in vivo through suppression of TAK1-NF-\u03baB pathway. Front Pharmacol 2018,9,1181","journal-title":"Front Pharmacol"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"3","DOI":"10.21273\/JASHS04446-18","volume":"144","author":"Jarret R.L.","year":"2019","unstructured":"Jarret R.L.; Barboza G.E.; Costa Batista F.R.; Berke T.; Chou Y.Y.; Hulse-Kemp A.; Ochoa-Alejo N.; Tripodi P.; Veres A.; Garcia C.C.; Csillery G.; Huang Y.K.; Kiss E.; Kovacs Z.; Kondrak M.; Arce-Rodriguez M.L.; Scaldaferro M.A.; Szoke A.; Capsicum - An abbreviated compendium. J Am Soc Hortic Sci 2019,144(1),3-22","journal-title":"J Am Soc Hortic Sci"},{"key":"ref=157","author":"Guala G.","unstructured":"Guala G.; Integrated Taxonomic Information System (ITIS). Available from: https:\/\/www.itis.gov\/ (Accessed Oct-2022)."},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/pca.2692","volume":"28","author":"Aranha B.C.","year":"2017","unstructured":"Aranha B.C.; Hoffmann J.F.; Barbieri R.L.; Rombaldi C.V.; Chaves F.C.; Untargeted metabolomic analysis of Capsicum spp. by GC\u2013MS. Phytochem Anal 2017,28(5),439-447","journal-title":"Phytochem Anal"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2131\/jts.21.3_195","volume":"21","author":"Saito A.","year":"1996","unstructured":"Saito A.; Yamamoto M.; Acute oral toxicity of capsaicin in mice and rats. J Toxicol Sci 1996,21(3),195-200","journal-title":"J Toxicol Sci"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3390\/molecules16021253","volume":"16","author":"Reyes-Escogido M.","year":"2011","unstructured":"Reyes-Escogido M.; Gonzalez-Mondragon E.G.; Vazquez-Tzompantzi E.; Chemical and pharmacological aspects of capsaicin. Molecules 2011,16(2),1253-1270","journal-title":"Molecules"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.phrs.2008.01.011","volume":"57","author":"Li J.","year":"2008","unstructured":"Li J.; Wang D.H.; Increased GFR and renal excretory function by activation of TRPV1 in the isolated perfused kidney. Pharmacol Res 2008,57(3),239-246","journal-title":"Pharmacol Res"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.tips.2007.10.016","volume":"29","author":"Suri A.","year":"2008","unstructured":"Suri A.; Szallasi A.; The emerging role of TRPV1 in diabetes and obesity. Trends Pharmacol Sci 2008,29(1),29-36","journal-title":"Trends Pharmacol Sci"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1080\/14756366.2022.2110089","volume":"37","author":"Caballero J.","year":"2022","unstructured":"Caballero J.; A new era for the design of TRPV1 antagonists and agonists with the use of structural information and molecular docking of capsaicin-like compounds. J Enzyme Inhib Med Chem 2022,37(1),2169-2178","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.1021\/acs.molpharmaceut.5b00641","volume":"12","author":"Darr\u00e9 L.","year":"2015","unstructured":"Darr\u00e9 L.; Domene C.; Binding of capsaicin to the TRPV1 ion channel. Mol Pharm 2015,12(12),4454-4465","journal-title":"Mol Pharm"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.bcp.2018.02.008","volume":"150","author":"Backes T.M.","year":"2018","unstructured":"Backes T.M.; R\u00f6ssler O.G.; Hui X.; Gr\u00f6tzinger C.; Lipp P.; Thiel G.; Stimulation of TRPV1 channels activates the AP-1 transcription factor. Biochem Pharmacol 2018,150,160-169","journal-title":"Biochem Pharmacol"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/cr.2011.205","volume":"22","author":"Luo Z.","year":"2012","unstructured":"Luo Z.; Ma L.; Zhao Z.; He H.; Yang D.; Feng X.; Ma S.; Chen X.; Zhu T.; Cao T.; Liu D.; Nilius B.; Huang Y.; Yan Z.; Zhu Z.; TRPV1 activation improves exercise endurance and energy metabolism through PGC-1and#945; upregulation in mice. Cell Res 2012,22(3),551-564","journal-title":"Cell Res"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"154182","DOI":"10.1016\/j.metabol.2020.154182","volume":"105","author":"Wei X.","year":"2020","unstructured":"Wei X.; Wei X.; Lu Z.; Li L.; Hu Y.; Sun F.; Jiang Y.; Ma H.; Zheng H.; Yang G.; Liu D.; Gao P.; Zhu Z.; Activation of TRPV1 channel antagonizes diabetic nephropathy through inhibiting endoplasmic reticulum-mitochondria contact in podocytes. Metabolism 2020,105,154182","journal-title":"Metabolism"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s10722-012-9846-2","volume":"59","author":"Hazarika T.K.","year":"2012","unstructured":"Hazarika T.K.; Citrus genetic diversity of north-east India, their distribution, ecogeography and ecobiology. Genet Resour Crop Evol 2012,59(6),1267-1280","journal-title":"Genet Resour Crop Evol"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3389\/fpls.2019.01167","volume":"10","author":"Sadka A.","year":"2019","unstructured":"Sadka A.; Shlizerman L.; Kamara I.; Blumwald E.; Primary metabolism in citrus fruit as affected by its unique structure. Front Plant Sci 2019,10(10),1167","journal-title":"Front Plant Sci"},{"key":"ref=170","doi-asserted-by":"publisher","DOI":"10.1201\/9780203216613","author":"Dugo G.","year":"2002","unstructured":"Dugo G.; Di Giacomo A.; Citrus: the genus citrus 2002","journal-title":"Citrus: the genus citrus"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/0031-9422(92)90003-9","volume":"31","author":"Champagne D.E.","year":"1992","unstructured":"Champagne D.E.; Koul O.; Isman M.B.; Scudder G.G.E.; Neil Towers G.H.; Biological activity of limonoids from the rutales. Phytochemistry 1992,31(2),377-394","journal-title":"Phytochemistry"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.lwt.2007.11.012","volume":"41","author":"Reinhard H.","year":"2008","unstructured":"Reinhard H.; Sager F.; Zoller O.; Citrus juice classification by SPME-GC-MS and electronic nose measurements. Lebensm Wiss Technol 2008,41(10),1906-1912","journal-title":"Lebensm Wiss Technol"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1021\/acs.jafc.0c07447","volume":"69","author":"Brendel R.","year":"2021","unstructured":"Brendel R.; Schwolow S.; Rohn S.; Weller P.; Volatilomic profiling of citrus juices by dual-detection HS-GC-MS-IMS and machine learning - An alternative authentication approach. J Agric Food Chem 2021,69(5),1727-1738","journal-title":"J Agric Food Chem"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"699666","DOI":"10.3389\/fnut.2021.699666","volume":"8","author":"Surendran S.","year":"2021","unstructured":"Surendran S.; Qassadi F.; Surendran G.; Lilley D.; Heinrich M.; Myrcene - what are the potential health benefits of this flavouring and aroma agent? Front Nutr 2021,8(699666),699666","journal-title":"Front Nutr"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"C1219","DOI":"10.1111\/j.1750-3841.2011.02421.x","volume":"76","author":"Jiang M.H.","year":"2011","unstructured":"Jiang M.H.; Yang L.; Zhu L.; Piao J.H.; Jiang J.G.; Comparative GC\/MS analysis of essential oils extracted by 3 methods from the bud of Citrus aurantium L. var. amara Engl. J Food Sci 2011,76(9),C1219-C1225","journal-title":"J Food Sci"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00897000450a","volume":"6","author":"Smith D.C.","year":"2001","unstructured":"Smith D.C.; Forland S.; Bachanos E.; Matejka M.; Barrett V.; Qualitative analysis of citrus fruit extracts by GC\/MS: An undergraduate experiment. Chem Educ 2001,6(1),28-31","journal-title":"Chem Educ"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1021\/jf970373s","volume":"45","author":"Benavente-Garc\u00eda O.","year":"1997","unstructured":"Benavente-Garc\u00eda O.; Castillo J.; Marin F.R.; Ortu\u00f1o A.; Del R\u00edo J.A.; Uses and properties of citrus flavonoids. J Agric Food Chem 1997,45(12),4505-4515","journal-title":"J Agric Food Chem"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/med.10028","volume":"23","author":"Kurogi Y.","year":"2003","unstructured":"Kurogi Y.; Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease. Med Res Rev 2003,23(1),15-31","journal-title":"Med Res Rev"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/8738760","volume":"2016","author":"Yan N.","year":"2016","unstructured":"Yan N.; Wen L.; Peng R.; Li H.; Liu H.; Peng H.; Sun Y.; Wu T.; Chen L.; Duan Q.; Sun Y.; Zhou Q.; Wei L.; Zhang Z.; Naringenin ameliorated kidney injury through Let-7a\/TGFBR1 signaling in diabetic nephropathy. J Diabetes Res 2016,2016,1-13","journal-title":"J Diabetes Res"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/j.1463-1326.2008.00869.x","volume":"10","author":"Ortiz-Andrade R.R.","year":"2008","unstructured":"Ortiz-Andrade R.R.; S\u00e1nchez-Salgado J.C.; Navarrete-V\u00e1zquez G.; Webster S.P.; Binnie M.; Garc\u00eda-Jim\u00e9nez S.; Le\u00f3n-Rivera I.; Cigarroa-V\u00e1zquez P.; Villalobos-Molina R.; Estrada-Soto S.; Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation. Diabetes Obes Metab 2008,10(11),1097-1104","journal-title":"Diabetes Obes Metab"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0278-6915(03)00016-4","volume":"41","author":"Bickers D.","year":"2003","unstructured":"Bickers D.; Calow P.; Greim H.; Hanifin J.M.; Rogers A.E.; Saurat J.H.; Sipes I.G.; Smith R.L.; Tagami H.; A toxicologic and dermatologic assessment of linalool and related esters when used as fragrance ingredients. Food Chem Toxicol 2003,41(7),919-942","journal-title":"Food Chem Toxicol"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/15376516.2012.743638","volume":"23","author":"Deepa B.","year":"2013","unstructured":"Deepa B.; Venkatraman C.; Effects of linalool on inflammation, matrix accumulation and podocyte loss in kidney of streptozotocin-induced diabetic rats. Toxicol Mech Methods 2013,23(4),223-234","journal-title":"Toxicol Mech Methods"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/labinvest.3780332","volume":"81","author":"Aaltonen P.","year":"2001","unstructured":"Aaltonen P.; Luimula P.; \u00c5str\u00f6m E.; Palmen T.; Gr\u00f6nholm T.; Palojoki E.; Jaakkola I.; Ahola H.; Tikkanen I.; Holth\u00f6fer H.; Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy. Lab Invest 2001,81(9),1185-1190","journal-title":"Lab Invest"},{"key":"ref=184","first-page":"121","volume":"40","author":"Deepa B.","year":"2011","unstructured":"Deepa B.; Anuradha C.V.; Linalool, a plant derived monoterpene alcohol, rescues kidney from diabetes-induced nephropathic changes via blood glucose reduction. Diabetol Croat 2011,40(4),121-138","journal-title":"Diabetol Croat"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.2337\/db08-0057","volume":"57","author":"Forbes J.M.","year":"2008","unstructured":"Forbes J.M.; Coughlan M.T.; Cooper M.E.; Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008,57(6),1446-1454","journal-title":"Diabetes"},{"key":"ref=186","first-page":"F765","volume":"251","author":"Baud L.","year":"1986","unstructured":"Baud L.; Ardaillou R.; Reactive oxygen species: Production and role in the kidney. Am J Physiol 1986,251(5 Pt 2),F765-F776","journal-title":"Am J Physiol"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1681\/ASN.2012111112","volume":"24","author":"Sedeek M.","year":"2013","unstructured":"Sedeek M.; Nasrallah R.; Touyz R.M.; H\u00e9bert R.L.; NADPH oxidases, reactive oxygen species, and the kidney: friend and foe. J Am Soc Nephrol 2013,24(10),1512-1518","journal-title":"J Am Soc Nephrol"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/ame2.12001","volume":"1","author":"Yan L.","year":"2018","unstructured":"Yan L.; Redox imbalance stress in diabetes mellitus: Role of the polyol pathway. Animal Model Exp Med 2018,1(1),7-13","journal-title":"Animal Model Exp Med"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1002\/mnfr.200600144","volume":"50","author":"Van Nguyen C.","year":"2006","unstructured":"Van Nguyen C.; Toxicity of the AGEs generated from the Maillard reaction: On the relationship of food-AGEs and biological-AGEs. Mol Nutr Food Res 2006,50(12),1140-1149","journal-title":"Mol Nutr Food Res"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/ki.1995.322","volume":"48","author":"Makino H.","year":"1995","unstructured":"Makino H.; Shikata K.; Hironaka K.; Kushiro M.; Yamasaki Y.; Sugimoto H.; Ota Z.; Araki N.; Horiuchi S.; Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy. Kidney Int 1995,48(2),517-526","journal-title":"Kidney Int"},{"key":"ref=191","first-page":"859083","volume":"2013","author":"Kummer R.","year":"2013","unstructured":"Kummer R.; Fachini-Queiroz F.C.; Estev\u00e3o-Silva C.F.; Grespan R.; Silva E.L.; Bersani-Amado C.A.; Cuman R.K.; Evaluation of anti-inflammatory activity of Citrus latifolia Tanaka essential oil and limonene in experimental mouse models. Evid. based Complement. Altern Med 2013,2013,859083","journal-title":"Altern Med"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.phytochem.2014.10.023","volume":"109","author":"Delort E.","year":"2015","unstructured":"Delort E.; Jaquier A.; Decorzant E.; Chapuis C.; Casilli A.; Fr\u00e9rot E.; Comparative analysis of three Australian finger lime (Citrus australasica) cultivars: Identification of unique citrus chemotypes and new volatile molecules. Phytochemistry 2015,109,111-124","journal-title":"Phytochemistry"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1039\/c3mb00020f","volume":"9","author":"Joglekar M.M.","year":"2013","unstructured":"Joglekar M.M.; Panaskar S.N.; Chougale A.D.; Kulkarni M.J.; Arvindekar A.U.; A novel mechanism for antiglycative action of limonene through stabilization of protein conformation. Mol Biosyst 2013,9(10),2463-2472","journal-title":"Mol Biosyst"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1039\/C4MB00548A","volume":"11","author":"Chaturvedi S.K.","year":"2015","unstructured":"Chaturvedi S.K.; Ahmad E.; Khan J.M.; Alam P.; Ishtikhar M.; Khan R.H.; Elucidating the interaction of limonene with bovine serum albumin: a multi-technique approach. Mol Biosyst 2015,11(1),307-316","journal-title":"Mol Biosyst"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1111\/jphp.12044","volume":"65","author":"Panaskar S.N.","year":"2013","unstructured":"Panaskar S.N.; Joglekar M.M.; Taklikar S.S.; Haldavnekar V.S.; Arvindekar A.U.; Aegle marmelos Correa leaf extract prevents secondary complications in streptozotocin-induced diabetic rats and demonstration of limonene as a potent antiglycating agent. J Pharm Pharmacol 2013,65(6),884-894","journal-title":"J Pharm Pharmacol"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"415","DOI":"10.5650\/jos.59.415","volume":"59","author":"Yoon W.J.","year":"2010","unstructured":"Yoon W.J.; Lee N.H.; Hyun C.G.; Limonene suppresses lipopolysaccharide-induced production of nitric oxide, prostaglandin E2, and pro-inflammatory cytokines in RAW 264.7 macrophages. J Oleo Sci 2010,59(8),415-421","journal-title":"J Oleo Sci"},{"key":"ref=197","first-page":"387","volume":"9","author":"Iwanage Y.","year":"1975","unstructured":"Iwanage Y.; Studies on d-limonene, as gallstone solubilizer. II. Acute and subacute toxicities. Oyo Yakuri 1975,9,387-401","journal-title":"Oyo Yakuri"},{"key":"ref=198","first-page":"20","volume":"2","author":"Kumar J.","year":"2009","unstructured":"Kumar J.; Verma V.; Goyal A.; Shahi A.K.; Sparoo R.; Sangwan R.S.; Qazi G.N.; Genetic diversity analysis in Cymbopogon species using DNA markers. Plant Omics 2009,2(1),20","journal-title":"Plant Omics"},{"key":"ref=199","first-page":"56","volume":"3","author":"Ganjewala D.","year":"2009","unstructured":"Ganjewala D.; Cymbopogon essential oils: Chemical compositions and bioactivities. Int J Essent Oil Res 2009,3(2-3),56-65","journal-title":"Int J Essent Oil Res"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4038\/gmj.v13i1.891","volume":"13","author":"Ilayperuma I.","year":"2009","unstructured":"Ilayperuma I.; Effects of intraperitoneal administration of Citral on male reproductive organs in the rat. Galen Med J 2009,13(1),29-32","journal-title":"Galen Med J"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1080\/13880209.2017.1301494","volume":"55","author":"Babukumar S.","year":"2017","unstructured":"Babukumar S.; Vinothkumar V.; Sankaranarayanan C.; Srinivasan S.; Geraniol, a natural monoterpene, ameliorates hyperglycemia by attenuating the key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats. Pharm Biol 2017,55(1),1442-1449","journal-title":"Pharm Biol"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jep.2013.11.027","volume":"151","author":"Kpoviessi S.","year":"2014","unstructured":"Kpoviessi S.; Bero J.; Agbani P.; Gbaguidi F.; Kpadonou-Kpoviessi B.; Sinsin B.; Accrombessi G.; Fr\u00e9d\u00e9rich M.; Moudachirou M.; Quetin-Leclercq J.; Chemical composition, cytotoxicity and in vitro antitrypanosomal and antiplasmodial activity of the essential oils of four Cymbopogon species from Benin. J Ethnopharmacol 2014,151(1),652-659","journal-title":"J Ethnopharmacol"},{"key":"ref=203","first-page":"13","volume":"17","author":"Robbins S.R.J.","year":"1983","unstructured":"Robbins S.R.J.; Selected markets for the essential oils of lemongrass, citronella and eucalyptus. Tropical Products Institute Report 1983,17,13","journal-title":"Tropical Products Institute Report"},{"key":"ref=204","first-page":"8","volume":"9","author":"Mishra C.","year":"2018","unstructured":"Mishra C.; Khalid M.A.; Tripathi D.; Mahdi A.A.; Comparative anti-diabetic study of three phytochemicals on high-fat diet and streptozotocin-induced diabetic dyslipidemic rats. Int J Biomed Adv Res 2018,9(8),8","journal-title":"Int J Biomed Adv Res"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.bbalip.2010.07.004","volume":"1801","author":"Katsukawa M.","year":"2010","unstructured":"Katsukawa M.; Nakata R.; Takizawa Y.; Hori K.; Takahashi S.; Inoue H.; Citral, a component of lemongrass oil, activates PPAR\u03b1 and \u03b3 and suppresses COX-2 expression. Biochim Biophys Acta Mol Cell Biol Lipids 2010,1801(11),1214-1220","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1080\/14786410902800681","volume":"23","author":"Sforcin J.M.","year":"2009","unstructured":"Sforcin J.M.; Amaral J.T.; Fernandes A.; Sousa J.P.B.; Bastos J.K.; Lemongrass effects on IL-1\u03b2 and IL-6 production by macrophages. Nat Prod Res 2009,23(12),1151-1159","journal-title":"Nat Prod Res"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00580-021-03205-4","volume":"30","author":"Zarandi M.H.","year":"2021","unstructured":"Zarandi M.H.; Sharifiyazdi H.; Nazifi S.; Ghaemi M.; Bakhtyari M.K.; Effects of citral on serum inflammatory factors and liver gene expression of IL-6 and TNF-alpha in experimental diabetes. Comp Clin Pathol 2021,30(3),351-361","journal-title":"Comp Clin Pathol"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s12272-001-1162-0","volume":"31","author":"Lee H.J.","year":"2008","unstructured":"Lee H.J.; Jeong H.S.; Kim D.J.; Noh Y.H.; Yuk D.Y.; Hong J.T.; Inhibitory effect of citral on NO production by suppression of iNOS expression and NF-\u03baB activation in RAW264.7 cells. Arch Pharm Res 2008,31(3),342-349","journal-title":"Arch Pharm Res"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1007\/s00210-020-01944-9","volume":"393","author":"El-Said Y.A.M.","year":"2020","unstructured":"El-Said Y.A.M.; Sallam N.A.A.; Ain-Shoka A.A.M.; Abdel-Latif H.A.T.; Geraniol ameliorates diabetic nephropathy via interference with miRNA-21\/PTEN\/Akt\/mTORC1 pathway in rats. Naunyn Schmiedebergs Arch Pharmacol 2020,393(12),2325-2337","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/2231-4040.79796","volume":"2","author":"Shah G.","year":"2011","unstructured":"Shah G.; Shri R.; Panchal V.; Sharma N.; Singh B.; Mann A.S.; Scientific basis for the therapeutic use of Cymbopogon citratus, stapf (Lemon grass). J Adv Pharm Technol Res 2011,2(1),3-8","journal-title":"J Adv Pharm Technol Res"},{"key":"ref=211","first-page":"1934578X0700201125","volume":"2","author":"Rauter A.P.","year":"2007","unstructured":"Rauter A.P.; Lopes R.G.; Martins A.; CGlycosylflavonoids: Identification, bioactivity and synthesis. Nat Prod Commun 2007,2(11),1934578X0700201125","journal-title":"Nat Prod Commun"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.foodchem.2008.02.045","volume":"110","author":"Figueirinha A.","year":"2008","unstructured":"Figueirinha A.; Paranhos A.; P\u00e9rez-Alonso J.J.; Santos-Buelga C.; Batista M.T.; Cymbopogon citratus leaves: Characterization of flavonoids by HPLC\u2013PDA\u2013ESI\/MS\/MS and an approach to their potential as a source of bioactive polyphenols. Food Chem 2008,110(3),718-728","journal-title":"Food Chem"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"e0004442","DOI":"10.1371\/journal.pntd.0004442","volume":"10","author":"Fonseca-Silva F.","year":"2016","unstructured":"Fonseca-Silva F.; Inacio J.D.F.; Canto-Cavalheiro M.M.; Menna-Barreto R.F.S.; Almeida-Amaral E.E.; Oral efficacy of apigenin against cutaneous leishmaniasis: Involvement of reactive oxygen species and autophagy as a mechanism of action. PLoS Negl Trop Dis 2016,10(2),e0004442","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"F414","DOI":"10.1152\/ajprenal.00393.2016","volume":"313","author":"Malik S.","year":"2017","unstructured":"Malik S.; Suchal K.; Khan S.I.; Bhatia J.; Kishore K.; Dinda A.K.; Arya D.S.; Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-\u03baB-TNF-\u03b1 and TGF-\u03b21-MAPK-fibronectin pathways. Am J Physiol Renal Physiol 2017,313(2),F414-F422","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.bbrc.2018.09.067","volume":"505","author":"Xu Y.","year":"2018","unstructured":"Xu Y.; Zhang J.; Fan L.; He X.; miR-423-5p suppresses high-glucose-induced podocyte injury by targeting Nox4. Biochem Biophys Res Commun 2018,505(2),339-345","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=216","first-page":"2006","volume":"13","author":"Hou Y.","year":"2021","unstructured":"Hou Y.; Zhang Y.; Lin S.; Yu Y.; Yang L.; Li L.; Wang W.; Protective mechanism of apigenin in diabetic nephropathy is related to its regulation of miR-423-5P-USF2 axis. Am J Transl Res 2021,13(4),2006-2020","journal-title":"Am J Transl Res"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3844\/ajptsp.2014.39.52","volume":"9","author":"Hossain C.M.","year":"2014","unstructured":"Hossain C.M.; Ghosh M.K.; Satapathy B.S.; Dey N.S.; Mukherjee B.; Apigenin causes biochemical modulation, GLUT4 and Cd38 alterations to improve diabetes and to protect damages of some vital organs in experimental diabetes. Am J Pharmacol Toxicol 2014,9(1),39-52","journal-title":"Am J Pharmacol Toxicol"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"681477","DOI":"10.3389\/fphar.2021.681477","volume":"12","author":"DeRango-Adem E.F.","year":"2021","unstructured":"DeRango-Adem E.F.; Blay J.; Does oral apigenin have real potential for a therapeutic effect in the context of human gastrointestinal and other cancers? Front Pharmacol 2021,12,681477","journal-title":"Front Pharmacol"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/978-981-15-1664-1_13","author":"Mukherjee B.","year":"2020","unstructured":"Mukherjee B.; Banerjee S.; Mondal L.; Chakraborty S.; Chanda D.; Perera J.A.; Bioactive flavonoid apigenin and its nanoformulations: a promising hope for diabetes and cancer. Nanomedicine for Bioactives 2020,367-382","journal-title":"Nanomedicine for Bioactives"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"9","DOI":"10.52756\/ijerr.2021.v25.002","volume":"25","author":"Chakrovorty A.","year":"2021","unstructured":"Chakrovorty A.; Bhattacharjee B.; Dey R.; Samadder A.; Nandi S.; Graphene: the magic carbon derived biological weapon for human welfare. Int Acad Publ House 2021,25,9-17","journal-title":"Int Acad Publ House"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.scienta.2006.12.021","volume":"112","author":"Syamkumar S.","year":"2007","unstructured":"Syamkumar S.; Sasikumar B.; Molecular marker based genetic diversity analysis of curcuma species from India. Sci Hortic 2007,112(2),235-241","journal-title":"Sci Hortic"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5528\/wjtm.v3.i2.84","volume":"3","author":"Samadder A.","year":"2014","unstructured":"Samadder A.; Khuda-Bukhsh A.R.; Nanotechnological approaches in diabetes treatment: A new horizon. World J Transl Med 2014,3(2),84-95","journal-title":"World J Transl Med"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12906-017-1739-7","volume":"17","author":"Chen L.","year":"2017","unstructured":"Chen L.; Liu T.; Wang Q.; Liu J.; Anti-inflammatory effect of combined tetramethylpyrazine, resveratrol and curcumin in vivo. BMC Complement Altern Med 2017,17(1),233","journal-title":"BMC Complement Altern Med"},{"key":"ref=224","first-page":"3335","volume":"21","author":"Widyananda M.H.","year":"2021","unstructured":"Widyananda M.H.; Ansori A.N.; Kharisma V.D.; Rizky W.C.; Dings T.G.; Rebezov M.; Maksimiuk N.; Denisenko A.; Nugraha A.P.; Investigating the potential of curcumin, demethoxycurcumin and bisdemethoxycurcumin as wild-type and mutant her2 inhibitors against various cancer types using bioinformatics analysis. Biochem Cell Arch 2021,21(2),3335-3343","journal-title":"Biochem Cell Arch"},{"key":"ref=225","first-page":"636053","volume":"2013","author":"Zhang D.W.","year":"2013","unstructured":"Zhang D.W.; Fu M.; Gao S.H.; Liu J.L.; Curcumin and diabetes: A systematic review. Evid.-. Based Complementary AlternMed 2013,2013,636053","journal-title":"Based Complementary AlternMed"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.2337\/dc12-0116","volume":"35","author":"Chuengsamarn S.","year":"2012","unstructured":"Chuengsamarn S.; Rattanamongkolgul S.; Luechapudiporn R.; Phisalaphong C.; Jirawatnotai S.; Curcumin extract for prevention of type 2 diabetes. Diabetes Care 2012,35(11),2121-2127","journal-title":"Diabetes Care"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1477-3155-5-3","volume":"5","author":"Bisht S.","year":"2007","unstructured":"Bisht S.; Feldmann G.; Soni S.; Ravi R.; Karikar C.; Maitra A.; Maitra A.; Polymeric nanoparticle-encapsulated curcumin (\u201cnanocurcumin\u201d): A novel strategy for human cancer therapy. J Nanobiotechnology 2007,5(1),3","journal-title":"J Nanobiotechnology"},{"key":"ref=228","doi-asserted-by":"publisher","first-page":"808","DOI":"10.2174\/1570159X20666220927121022","volume":"20","author":"Chakrovorty A.","year":"2022","unstructured":"Chakrovorty A.; Bhattacharjee B.; Saxena A.; Samadder A.; Nandi S.; Current naturopathy to combat Alzheimer\u2019s disease. Curr Neuropharmacol 2022,20,808-841","journal-title":"Curr Neuropharmacol"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/ptr.6226","volume":"33","author":"Tabrizi R.","year":"2019","unstructured":"Tabrizi R.; Vakili S.; Akbari M.; Mirhosseini N.; Lankarani K.B.; Rahimi M.; Mobini M.; Jafarnejad S.; Vahedpoor Z.; Asemi Z.; The effects of curcumin-containing supplements on biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials. Phytother Res 2019,33(2),253-262","journal-title":"Phytother Res"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"9183","DOI":"10.3390\/molecules20059183","volume":"20","author":"He Y.","year":"2015","unstructured":"He Y.; Yue Y.; Zheng X.; Zhang K.; Chen S.; Du Z.; Curcumin, inflammation, and chronic diseases: How are they linked? Molecules 2015,20(5),9183-9213","journal-title":"Molecules"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0891-5849(00)00294-X","volume":"28","author":"Motterlini R.","year":"2000","unstructured":"Motterlini R.; Foresti R.; Bassi R.; Green C.J.; Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 2000,28(8),1303-1312","journal-title":"Free Radic Biol Med"},{"key":"ref=232","first-page":"1208","volume":"13","author":"Karlowee H.","year":"2019","unstructured":"Karlowee H.; Gumay A.R.; Turmeric as a preventive agent of oxidative stress and diabetic nephropathy in alloxan induced wistar rats. Pak J Med Health Sci 2019,13(4),1208-1213","journal-title":"Pak J Med Health Sci"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/biom5010194","volume":"5","author":"Nowotny K.","year":"2015","unstructured":"Nowotny K.; Jung T.; H\u00f6hn A.; Weber D.; Grune T.; Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules 2015,5(1),194-222","journal-title":"Biomolecules"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1002\/mnfr.201100080","volume":"55","author":"Soetikno V.","year":"2011","unstructured":"Soetikno V.; Watanabe K.; Sari F.R.; Harima M.; Thandavarayan R.A.; Veeraveedu P.T.; Arozal W.; Sukumaran V.; Lakshmanan A.P.; Arumugam S.; Suzuki K.; Curcumin attenuates diabetic nephropathy by inhibiting PKC-\u03b1 and PKC-\u03b21 activity in streptozotocin-induced type I diabetic rats. Mol Nutr Food Res 2011,55(11),1655-1665","journal-title":"Mol Nutr Food Res"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1681\/ASN.V11125","volume":"11","author":"Riser B.L.","year":"2000","unstructured":"Riser B.L.; Denichilo M.; Cortes P.; Baker C.; Grondin J.M.; Yee J.; Narins R.G.; Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 2000,11(1),25-38","journal-title":"J Am Soc Nephrol"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.mce.2012.10.024","volume":"365","author":"Huang J.","year":"2013","unstructured":"Huang J.; Huang K.; Lan T.; Xie X.; Shen X.; Liu P.; Huang H.; Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway. Mol Cell Endocrinol 2013,365(2),231-240","journal-title":"Mol Cell Endocrinol"},{"key":"ref=237","doi-asserted-by":"publisher","first-page":"e0164135","DOI":"10.1371\/journal.pone.0164135","volume":"11","author":"Yuan F.","year":"2016","unstructured":"Yuan F.; Kolb R.; Pandey G.; Li W.; Sun L.; Liu F.; Sutterwala F.S.; Liu Y.; Zhang W.; Involvement of the NLRC4-inflammasome in diabetic nephropathy. PLoS One 2016,11(10),e0164135","journal-title":"PLoS One"},{"key":"ref=238","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/1516985","volume":"2017","author":"Lu M.","year":"2017","unstructured":"Lu M.; Yin N.; Liu W.; Cui X.; Chen S.; Wang E.; Curcumin ameliorates diabetic nephropathy by suppressing NLRP3 inflammasome signaling. BioMed Res Int 2017,2017,1-10","journal-title":"BioMed Res Int"},{"key":"ref=239","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.3390\/antiox11101994","volume":"11","author":"Zhang J.","year":"2022","unstructured":"Zhang J.; Li Q.; Zhang X.; Chen Y.; Lu Y.; Wang X.; Zhang L.; Wang T.; Bisdemethoxycurcumin alleviates dextran sodium sulfate-induced colitis via inhibiting NLRP3 inflammasome activation and modulating the gut microbiota in mice. Antioxidants 2022,11(10),1994","journal-title":"Antioxidants"},{"key":"ref=240","doi-asserted-by":"publisher","first-page":"914","DOI":"10.2174\/1874467214666210301121020","volume":"14","author":"Tang J.","year":"2021","unstructured":"Tang J.; Tan X.; Huang X.; Zhang J.; Chen L.; Li A.; Wang D.; Dual targeting of autophagy and NF-\u03baB pathway by PPAR\u03b3 contributes to the inhibitory effect of demethoxycurcumin on NLRP3 inflammasome priming. Curr Mol Pharmacol 2021,14(5),914-921","journal-title":"Curr Mol Pharmacol"},{"key":"ref=241","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.intimp.2014.08.023","volume":"23","author":"Sun L.N.","year":"2014","unstructured":"Sun L.N.; Yang Z.Y.; Lv S.S.; Liu X.C.; Guan G.J.; Liu G.; Curcumin prevents diabetic nephropathy against inflammatory response via reversing caveolin-1 Tyr14 phosphorylation influenced TLR4 activation. Int Immunopharmacol 2014,23(1),236-246","journal-title":"Int Immunopharmacol"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"108515","DOI":"10.1016\/j.jnutbio.2020.108515","volume":"87","year":"2021","unstructured":"ALTamimi, J.Z.; AlFaris, N.A.; AL-Farga, A.M.; Alshammari, G.M.; BinMowyna, M.N.; Yahya, M.A. Curcumin reverses diabetic nephropathy in streptozotocin-induced diabetes in rats by inhibition of PKC\u03b2\/p66Shc axis and activation of FOXO-3a. J Nutr Biochem 2021,87,108515","journal-title":"J Nutr Biochem"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2147\/JIR.S212577","volume":"12","author":"Meshkibaf M.H.","year":"2019","unstructured":"Meshkibaf M.H.; Maleknia M.; Noroozi S.; Effect of curcumin on gene expression and protein level of methionine sulfoxide reductase A (MSRA), SOD, CAT and GPx in Freund\u2019s adjuvant inflammation-induced male rats. J Inflamm Res 2019,12,241-249","journal-title":"J Inflamm Res"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.toxlet.2007.03.011","volume":"170","author":"Nishinaka T.","year":"2007","unstructured":"Nishinaka T.; Ichijo Y.; Ito M.; Kimura M.; Katsuyama M.; Iwata K.; Miura T.; Terada T.; Yabe-Nishimura C.; Curcumin activates human glutathione S-transferase P1 expression through antioxidant response element. Toxicol Lett 2007,170(3),238-247","journal-title":"Toxicol Lett"},{"key":"ref=245","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3349\/ymj.2016.57.3.664","volume":"57","author":"Kim B.H.","year":"2016","unstructured":"Kim B.H.; Lee E.S.; Choi R.; Nawaboot J.; Lee M.Y.; Lee E.Y.; Kim H.S.; Chung C.H.; Protective effects of curcumin on renal oxidative stress and lipid metabolism in a rat model of type 2 diabetic nephropathy. Yonsei Med J 2016,57(3),664-673","journal-title":"Yonsei Med J"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1080\/13880209.2019.1688843","volume":"57","author":"Tu Q.","year":"2019","unstructured":"Tu Q.; Li Y.; Jin J.; Jiang X.; Ren Y.; He Q.; Curcumin alleviates diabetic nephropathy via inhibiting podocyte mesenchymal transdifferentiation and inducing autophagy in rats and MPC5 cells. Pharm Biol 2019,57(1),778-786","journal-title":"Pharm Biol"},{"key":"ref=247","doi-asserted-by":"publisher","first-page":"115751","DOI":"10.1016\/j.jep.2022.115751","volume":"300","author":"Zhang M.","year":"2023","unstructured":"Zhang M.; Lu P.; Zhao F.; Sun X.; Ma W.; Tang J.; Zhang C.; Ji H.; Wang X.; Uncovering the molecular mechanisms of Curcumae rhizoma against myocardial fibrosis using network pharmacology and experimental validation. J Ethnopharmacol 2023,300,115751","journal-title":"J Ethnopharmacol"},{"key":"ref=248","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-57415-4_37","author":"de Oliveira Filho J.G.","year":"2021","unstructured":"de Oliveira Filho J.G.; de Almeida M.J.; Sousa T.L.; dos Santos D.C.; Egea M.B.; Bioactive Compounds of Turmeric (Curcuma longa L.). Bioactive Compounds in Underutilized Vegetables and Legumes Reference Series in Phytochemistry 2021","journal-title":"Bioactive Compounds in Underutilized Vegetables and Legumes Reference Series in Phytochemistry"},{"key":"ref=249","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4103\/wjtcm.wjtcm_12_19","volume":"5","author":"Ye M.","year":"2019","unstructured":"Ye M.; Shang Z-P.; Xu L-L.; Lu Y-Y.; Guan M.; Li D-Y.; Le Z-Y.; Bai Z-L.; Qiao X.; Advances in chemical constituents and quality control of turmeric. World J Tradit Chin Med 2019,5(2),116","journal-title":"World J Tradit Chin Med"},{"key":"ref=250","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/mc.22280","volume":"55","author":"Dong Y.","year":"2016","unstructured":"Dong Y.; Yin S.; Song X.; Huo Y.; Fan L.; Ye M.; Hu H.; Involvement of ROS-p38-H2AX axis in novel curcumin analogues-induced apoptosis in breast cancer cells. Mol Carcinog 2016,55(4),323-334","journal-title":"Mol Carcinog"},{"key":"ref=251","doi-asserted-by":"publisher","first-page":"e0162926","DOI":"10.1371\/journal.pone.0162926","volume":"11","author":"Sueth-Santiago V.","year":"2016","unstructured":"Sueth-Santiago V.; Moraes J.B.B.; Sobral Alves E.S.; Vannier-Santos M.A.; Freire-de-Lima C.G.; Castro R.N.; Mendes-Silva G.P.; Del Cistia C.N.; Magalh\u00e3es L.G.; Andricopulo A.D.; Sant\u2019Anna C.M.R.; Decot\u00e9-Ricardo D.; Freire de Lima M.E.; The effectiveness of natural diarylheptanoids against trypanosoma cruzi: Cytotoxicity, ultrastructural alterations and molecular modeling studies. PLoS One 2016,11(9),e0162926","journal-title":"PLoS One"},{"key":"ref=252","doi-asserted-by":"publisher","first-page":"12698","DOI":"10.1039\/C8NJ01819G","volume":"42","author":"Li Y.","year":"2018","unstructured":"Li Y.; Toscano M.; Mazzone G.; Russo N.; Antioxidant properties and free radical scavenging mechanisms of cyclocurcumin. New J Chem 2018,42(15),12698-12705","journal-title":"New J Chem"},{"key":"ref=253","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.3892\/ijmm.2017.2926","volume":"39","author":"Fu M.","year":"2017","unstructured":"Fu M.; Chen L.; Zhang L.; Yu X.; Yang Q.; Cyclocurcumin, a curcumin derivative, exhibits immune-modulating ability and is a potential compound for the treatment of rheumatoid arthritis as predicted by the MM-PBSA method. Int J Mol Med 2017,39(5),1164-1172","journal-title":"Int J Mol Med"},{"key":"ref=254","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.fitote.2017.06.011","volume":"121","author":"Zhou C.X.","year":"2017","unstructured":"Zhou C.X.; Zhang L.S.; Chen F.F.; Wu H.S.; Mo J.X.; Gan L.S.; Terpenoids from Curcuma wenyujin increased glucose consumption on HepG2 cells. Fitoterapia 2017,121,141-145","journal-title":"Fitoterapia"},{"key":"ref=255","doi-asserted-by":"publisher","first-page":"312","DOI":"10.14719\/pst.1427","volume":"9","author":"Das J.M.","year":"2022","unstructured":"Das J.M.; Sarma B.; Nath N.; Borthakur M.K.; Sustainable prospective of some selected species from moraceae and araceae family of Northeast India: A review. Plant Sci Today 2022,9(2),312-321","journal-title":"Plant Sci Today"},{"key":"ref=256","first-page":"23","volume":"2","author":"Yende S.","year":"2008","unstructured":"Yende S.; Harle U.; Rajgure D.; Tuse T.; Vyawahare N.; Pharmacological profile of Acorus calamus: an overview. Phcog Rev 2008,2(4),23","journal-title":"Phcog Rev"},{"key":"ref=257","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.3390\/jcm9041176","volume":"9","author":"Sharma V.","year":"2020","unstructured":"Sharma V.; Sharma R.; Gautam D.; Kuca K.; Nepovimova E.; Martins N.; Role of Vacha (Acorus calamus Linn.) in neurological and metabolic disorders: evidence from ethnopharmacology, phytochemistry, pharmacology and clinical study. J Clin Med 2020,9(4),1176","journal-title":"J Clin Med"},{"key":"ref=258","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3760\/cma.j.issn.0366-6999.20122445","volume":"126","author":"Zhao Z.F.","year":"2013","unstructured":"Zhao Z.F.; Zhou L.L.; Chen X.; Cheng Y.X.; Hou F.F.; Nie J.; Acortatarin A inhibits high glucose-induced extracellular matrix production in mesangial cells. Chin Med J 2013,126(7),1230-1235","journal-title":"Chin Med J"},{"key":"ref=259","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.2174\/1386207323666201230093510","volume":"24","author":"Samadder A.","year":"2021","unstructured":"Samadder A.; Dey S.; Sow P.; Das R.; Nandi S.; Das J.; Bhattacharjee B.; Chakrovorty A.; Biswas M.; Guptaroy P.; Phyto-chlorophyllin prevents food additive induced genotoxicity and mitochondrial dysfunction via cytochrome c mediated pathway in mice model. Comb Chem High Throughput Screen 2021,24(10),1618-1627","journal-title":"Comb Chem High Throughput Screen"},{"key":"ref=260","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.etap.2016.07.006","volume":"46","author":"Das J.","year":"2016","unstructured":"Das J.; Samadder A.; Mondal J.; Abraham S.K.; Khuda-Bukhsh A.R.; Nano-encapsulated chlorophyllin significantly delays progression of lung cancer both in in vitro and in vivo models through activation of mitochondrial signaling cascades and drug-DNA interaction. Environ Toxicol Pharmacol 2016,46,147-157","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref=261","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/carcin\/bgi068","volume":"26","author":"Fahey J.W.","year":"2005","unstructured":"Fahey J.W.; Stephenson K.K.; Dinkova-Kostova A.T.; Egner P.A.; Kensler T.W.; Talalay P.; Chlorophyll, chlorophyllin and related tetrapyrroles are significant inducers of mammalian phase 2 cytoprotective genes. Carcinogenesis 2005,26(7),1247-1255","journal-title":"Carcinogenesis"},{"key":"ref=262","first-page":"141","volume":"24","author":"Abouzaid O.","year":"2013","unstructured":"Abouzaid O.; Ameliorating role of chlorophyllin on oxidative stress induced by pirimiphos methyl in erythrocytes and brain of rats. Benha Vet Med J 2013,24(1),141-150","journal-title":"Benha Vet Med J"},{"key":"ref=263","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1007\/s00210-020-01912-3","volume":"393","author":"Suryavanshi S.V.","year":"2020","unstructured":"Suryavanshi S.V.; Gharpure M.; Kulkarni Y.A.; Sodium copper chlorophyllin attenuates adenine-induced chronic kidney disease via suppression of TGF-beta and inflammatory cytokines. Naunyn Schmiedebergs Arch Pharmacol 2020,393(11),2029-2041","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=264","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1017\/jns.2016.41","volume":"5","author":"Panche A.N.","year":"2016","unstructured":"Panche A.N.; Diwan A.D.; Chandra S.R.; Flavonoids: An overview. J Nutr Sci 2016,5,e47","journal-title":"J Nutr Sci"},{"key":"ref=265","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/nu12020457","volume":"12","author":"Kopustinskiene D.M.","year":"2020","unstructured":"Kopustinskiene D.M.; Jakstas V.; Savickas A.; Bernatoniene J.; Flavonoids as anticancer agents. Nutrients 2020,12(2),457","journal-title":"Nutrients"},{"key":"ref=266","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13020-021-00485-4","volume":"16","author":"Hu Q.","year":"2021","unstructured":"Hu Q.; Qu C.; Xiao X.; Zhang W.; Jiang Y.; Wu Z.; Song D.; Peng X.; Ma X.; Zhao Y.; Flavonoids on diabetic nephropathy: Advances and therapeutic opportunities. Chin Med 2021,16(1),74","journal-title":"Chin Med"},{"key":"ref=267","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11130-004-0049-7","volume":"59","author":"Yao L.H.","year":"2004","unstructured":"Yao L.H.; Jiang Y.M.; Shi J.; Tom\u00e1s-Barber\u00e1n F.A.; Datta N.; Singanusong R.; Chen S.S.; Flavonoids in food and their health benefits. Plant Foods Hum Nutr 2004,59(3),113-122","journal-title":"Plant Foods Hum Nutr"},{"key":"ref=268","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1002\/bab.2272","volume":"69","author":"Amri J.","year":"2022","unstructured":"Amri J.; Alaee M.; Babaei R.; Salemi Z.; Meshkani R.; Ghazavi A.; Akbari A.; Salehi M.; Biochanin-A has antidiabetic, antihyperlipidemic, antioxidant, and protective effects on diabetic nephropathy via suppression of TGF-\u03b21 and PAR-2 genes expression in kidney tissues of STZ-induced diabetic rats. Biotechnol Appl Biochem 2022,69(5),2112-2121","journal-title":"Biotechnol Appl Biochem"},{"key":"ref=269","first-page":"16","volume":"5","author":"Ramada M.M.","year":"2021","unstructured":"Ramada M.M.; Ali M.A.; Albohy A.; Zada S.K.; Tolba M.F.; Abu-ELElla D.; Molecular modeling studies on biochanin-a as a potential dual inhibitor for VEGFR-2 and Cyclin D1-CDK-4 complex. Arch Pharm Sci Ain Shams Univ 2021,5(1),16-32","journal-title":"Arch Pharm Sci Ain Shams Univ"},{"key":"ref=270","doi-asserted-by":"publisher","first-page":"117","DOI":"10.21010\/ajtcam.v13i3.15","volume":"13","author":"Sun M.Y.","year":"2016","unstructured":"Sun M.Y.; Ye Y.; Xiao L.; Rahman K.; Xiad W.; Zhang H.; Daidzein: A review of pharmacological effects. Afr J Tradit Complement Altern Med 2016,13(3),117-132","journal-title":"Afr J Tradit Complement Altern Med"},{"key":"ref=271","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fasebj.2020.34.s1.05292","volume":"34","author":"Laddha A.P.","year":"2020","unstructured":"Laddha A.P.; Kulkarni Y.A.; Daidzein attenuates kidney damage in diabetic rats. FASEB J 2020,34(S1),1","journal-title":"FASEB J"},{"key":"ref=272","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1080\/01480545.2020.1833906","volume":"45","author":"Laddha A.P.","year":"2022","unstructured":"Laddha A.P.; Murugesan S.; Kulkarni Y.A.; In-vivo and in-silico toxicity studies of daidzein: an isoflavone from soy. Drug Chem Toxicol 2022,45(3),1408-1416","journal-title":"Drug Chem Toxicol"},{"key":"ref=273","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2174\/1871530311313020003","volume":"13","author":"Katyal T.","year":"2013","unstructured":"Katyal T.; Garg A.; Budhiraja R.; Combination of daidzein, hemin and bms182874 halts the progression of diabetes-induced experimental nephropathy. Endocr Metab Immune Disord Drug Targets 2013,13(2),152-162","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=274","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.neuint.2012.03.011","volume":"60","author":"Qian Y.","year":"2012","unstructured":"Qian Y.; Guan T.; Huang M.; Cao L.; Li Y.; Cheng H.; Jin H.; Yu D.; Neuroprotection by the soy isoflavone, genistein, via inhibition of mitochondria-dependent apoptosis pathways and reactive oxygen induced-NF-\u03baB activation in a cerebral ischemia mouse model. Neurochem Int 2012,60(8),759-767","journal-title":"Neurochem Int"},{"key":"ref=275","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.vph.2011.07.007","volume":"55","author":"Elmarakby A.A.","year":"2011","unstructured":"Elmarakby A.A.; Ibrahim A.S.; Faulkner J.; Mozaffari M.S.; Liou G.I.; Abdelsayed R.; Tyrosine kinase inhibitor, genistein, reduces renal inflammation and injury in streptozotocin-induced diabetic mice. Vascul Pharmacol 2011,55(5-6),149-156","journal-title":"Vascul Pharmacol"},{"key":"ref=276","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/510212","volume":"2013","author":"Kim M.J.","year":"2013","unstructured":"Kim M.J.; Lim Y.; Protective effect of short-term genistein supplementation on the early stage in diabetes-induced renal damage. Mediators Inflamm 2013,2013,1-14","journal-title":"Mediators Inflamm"},{"key":"ref=277","doi-asserted-by":"publisher","first-page":"4823","DOI":"10.12659\/MSM.910868","volume":"24","author":"Wang Y.","year":"2018","unstructured":"Wang Y.; Li Y.; Zhang T.; Chi Y.; Liu M.; Liu Y.; Genistein and myd88 activate autophagy in high glucose-induced renal podocytes in vitro. Med Sci Monit 2018,24,4823-4831","journal-title":"Med Sci Monit"},{"key":"ref=278","doi-asserted-by":"crossref","first-page":"0300060520903642","DOI":"10.1177\/0300060520903642","volume":"202048","author":"Xiong C.","year":"2020","unstructured":"Xiong C.; Wu Q.; Fang M.; Li H.; Chen B.; Chi T.; Protective effects of luteolin on nephrotoxicity induced by long-term hyperglycaemia in rats. Int J Med Res 2020,202048(4),0300060520903642","journal-title":"Int J Med Res"},{"key":"ref=279","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1055\/a-0998-7985","volume":"129","author":"Zhang M.","year":"2021","unstructured":"Zhang M.; He L.; Liu J.; Zhou L.; Luteolin attenuates diabetic nephropathy through suppressing inflammatory response and oxidative stress by inhibiting STAT3 pathway. Exp Clin Endocrinol Diabetes 2021,129(10),729-739","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref=280","doi-asserted-by":"publisher","first-page":"17","DOI":"10.9790\/3013-04010017023","volume":"4","author":"Asuzu I.U.","year":"2014","unstructured":"Asuzu I.U.; Asuzu I.U.; Luteolin isolate from the methanol extract identified as the single-carbon compound responsible for broad antiulcer activities of Cassia singueana Leaves. IOSR J Pharm 2014,4(10),17-23","journal-title":"IOSR J Pharm"},{"key":"ref=281","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.toxlet.2013.09.012","volume":"223","author":"Das S.","year":"2013","unstructured":"Das S.; Das J.; Samadder A.; Paul A.; Khuda-Bukhsh A.R.; Strategic formulation of apigenin-loaded PLGA nanoparticles for intracellular trafficking, DNA targeting and improved therapeutic effects in skin melanoma in vitro. Toxicol Lett 2013,223(2),124-138","journal-title":"Toxicol Lett"},{"key":"ref=282","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jams.2013.07.002","volume":"6","author":"Das S.","year":"2013","unstructured":"Das S.; Das J.; Paul A.; Samadder A.; Khuda-Bukhsh A.R.; Apigenin, a bioactive flavonoid from Lycopodium clavatum, stimulates nucleotide excision repair genes to protect skin keratinocytes from ultraviolet B-induced reactive oxygen species and DNA damage. J Acupunct Meridian Stud 2013,6(5),252-262","journal-title":"J Acupunct Meridian Stud"},{"key":"ref=283","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.fct.2013.09.037","volume":"62","author":"Das S.","year":"2013","unstructured":"Das S.; Das J.; Samadder A.; Paul A.; Khuda-Bukhsh A.R.; Efficacy of PLGA-loaded apigenin nanoparticles in Benzo[a]pyrene and ultraviolet-B induced skin cancer of mice: Mitochondria mediated apoptotic signalling cascades. Food Chem Toxicol 2013,62,670-680","journal-title":"Food Chem Toxicol"},{"key":"ref=284","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1248\/bpb.b19-00296","volume":"42","author":"Harishkumar R.","year":"2019","unstructured":"Harishkumar R.; Reddy L.P.K.; Karadkar S.H.; Murad M.A.; Karthik S.S.; Manigandan S.; Selvaraj C.I.; Christopher J.G.; Toxicity and selective biochemical assessment of quercetin, gallic acid, and curcumin in zebrafish. Biol Pharm Bull 2019,42(12),1969-1976","journal-title":"Biol Pharm Bull"},{"key":"ref=285","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jnutbio.2015.10.015","volume":"30","author":"Mu M.","year":"2016","unstructured":"Mu M.; An P.; Wu Q.; Shen X.; Shao D.; Wang H.; Zhang Y.; Zhang S.; Yao H.; Min J.; Wang F.; The dietary flavonoid myricetin regulates iron homeostasis by suppressing hepcidin expression. J Nutr Biochem 2016,30,53-61","journal-title":"J Nutr Biochem"},{"key":"ref=286","first-page":"139","volume":"3","author":"Bigoniya P.","year":"2013","unstructured":"Bigoniya P.; Singh C.S.; Shrivastava B.; In vivo and in vitro hepatoprotective potential of kaempferol, a flavone glycoside from Capparis spinosa. Int J Pharm Biol Sci 2013,3(4),139-152","journal-title":"Int J Pharm Biol Sci"},{"key":"ref=287","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.scitotenv.2019.03.381","volume":"671","author":"Samadder A.","year":"2019","unstructured":"Samadder A.; Tarafdar D.; Das R.; Khuda-Bukhsh A.R.; Abraham S.K.; Efficacy of nanoencapsulated pelargonidin in ameliorating pesticide toxicity in fish and L6 cells: Modulation of oxidative stress and signalling cascade. Sci Total Environ 2019,671,466-473","journal-title":"Sci Total Environ"},{"key":"ref=288","doi-asserted-by":"publisher","first-page":"105586","DOI":"10.1016\/j.ejps.2020.105586","volume":"156","author":"Dey R.","year":"2021","unstructured":"Dey R.; Nandi S.; Samadder A.; \u201cPelargonidin mediated selective activation of p53 and parp proteins in preventing food additive induced genotoxicity: an in vivo coupled in silico molecular docking study\u201d. Eur J Pharm Sci 2021,156,105586","journal-title":"Eur J Pharm Sci"},{"key":"ref=289","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1055\/s-0043-100017","volume":"83","author":"Samadder A.","year":"2017","unstructured":"Samadder A.; Tarafdar D.; Abraham S.; Ghosh K.; Khuda-Bukhsh A.; Nano-pelargonidin protects hyperglycemic-induced L6 cells against mitochondrial dysfunction. Planta Med 2017,83(5),468-475","journal-title":"Planta Med"},{"key":"ref=290","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.etap.2016.02.010","volume":"43","author":"Samadder A.","year":"2016","unstructured":"Samadder A.; Abraham S.K.; Khuda-Bukhsh A.R.; Nanopharmaceutical approach using pelargonidin towards enhancement of efficacy for prevention of alloxan-induced DNA damage in L6 cells via activation of PARP and p53. Environ Toxicol Pharmacol 2016,43,27-37","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref=291","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1089\/jmf.2018.4230","volume":"22","author":"Lee I.C.","year":"2019","unstructured":"Lee I.C.; Bae J.S.; Pelargonidin protects against renal injury in a mouse model of sepsis. J Med Food 2019,22(1),57-61","journal-title":"J Med Food"},{"key":"ref=292","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/ptr.5642","volume":"30","author":"Smeriglio A.","year":"2016","unstructured":"Smeriglio A.; Barreca D.; Bellocco E.; Trombetta D.; Chemistry, pharmacology and health benefits of anthocyanins. Phytother Res 2016,30(8),1265-1286","journal-title":"Phytother Res"},{"key":"ref=293","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.3390\/app9245420","volume":"9","author":"Francomano F.","year":"2019","unstructured":"Francomano F.; Caruso, A.; Barbarossa, A.; Fazio, A.; La Torre, C.; Ceramella, J.; Mallamaci, R.; Saturnino, C.; Iacopetta, D.; Sinicropi, M.S. \u03b2-Caryophyllene: A sesquiterpene with countless biological properties. Appl Sci (Basel) 2019,9(24),5420","journal-title":"Appl Sci (Basel)"},{"key":"ref=294","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.3390\/nu12102963","volume":"12","author":"Hashiesh H.M.","year":"2020","unstructured":"Hashiesh H.M.; Meeran M.F.N.; Sharma C.; Sadek B.; Kaabi J.A.; Ojha S.K.; Therapeutic potential of \u03b2-caryophyllene: A dietary cannabinoid in diabetes and associated complications. Nutrients 2020,12(10),2963","journal-title":"Nutrients"},{"key":"ref=295","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejphar.2013.01.011","volume":"702","author":"Abbas M.A.","year":"2013","unstructured":"Abbas M.A.; Taha, M.O.; Zihlif, M.A.; Disi, A.M. \u03b2-Caryophyllene causes regression of endometrial implants in a rat model of endometriosis without affecting fertility. Eur J Pharmacol 2013,702(1-3),12-19","journal-title":"Eur J Pharmacol"},{"key":"ref=296","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.freeradbiomed.2012.01.014","volume":"52","author":"Horv\u00e1th B.","year":"2012","unstructured":"Horv\u00e1th B.; Mukhopadhyay, P.; Kechrid, M.; Patel, V.; Tanchian, G.; Wink, D.A.; Gertsch, J.; Pacher, P. \u03b2-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner. Free Radic Biol Med 2012,52(8),1325-1333","journal-title":"Free Radic Biol Med"},{"key":"ref=297","doi-asserted-by":"publisher","first-page":"106556","DOI":"10.1016\/j.intimp.2020.106556","volume":"84","author":"Li H.","year":"2020","unstructured":"Li H.; Wang, D.; Chen, Y.; Yang, M. \u03b2-Caryophyllene inhibits high glucose-induced oxidative stress, inflammation and extracellular matrix accumulation in mesangial cells. Int Immunopharmacol 2020,84,106556","journal-title":"Int Immunopharmacol"},{"key":"ref=298","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/4212331","volume":"2022","author":"Rajab B.S.","year":"2022","unstructured":"Rajab B.S.; Albukhari T.A.; Khan A.A.; Refaat B.; Almehmadi S.J.; Nasreldin N.; Elshopakey G.E.; El-Boshy M.; Antioxidative and anti-inflammatory protective effects of \u03b2-caryophyllene against amikacin-induced nephrotoxicity in rat by regulating the Nrf2\/AMPK\/AKT and NF-\u03baB\/TGF-\u03b2\/KIM-1 molecular pathways. Oxid Med Cell Longev 2022,2022,1-12","journal-title":"Oxid Med Cell Longev"},{"key":"ref=299","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1039\/C5FO00607D","volume":"6","author":"Lo J.Y.","year":"2015","unstructured":"Lo J.Y.; Kamarudin M.N.A.; Hamdi O.A.A.; Awang K.; Kadir H.A.; Curcumenol isolated from Curcuma zedoaria suppresses Akt-mediated NF-\u03baB activation and p38 MAPK signaling pathway in LPS-stimulated BV-2 microglial cells. Food Funct 2015,6(11),3550-3559","journal-title":"Food Funct"},{"key":"ref=300","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s000110050361","volume":"47","author":"Yoshioka T.","year":"1998","unstructured":"Yoshioka T.; Fujii E.; Endo M.; Wada K.; Tokunaga Y.; Shiba N.; Hohsho H.; Shibuya H.; Muraki T.; Antiinflammatory potency of dehydrocurdione, a zedoary-derived sesquiterpene. Inflamm Res 1998,47(12),476-481","journal-title":"Inflamm Res"},{"key":"ref=301","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/ptr.6028","volume":"32","author":"Ohnishi M.","year":"2018","unstructured":"Ohnishi M.; Urasaki T.; Egusa K.; Kunobu C.; Harada T.; Shinkado R.; Nishi H.; Maehara S.; Kitamura C.; Hata T.; Ohashi K.; Shibuya H.; Inoue A.; Curcuma sp.-derived dehydrocurdione induces heme oxygenase-1 through a Michael reaction between its \u03b1, \u03b2-unsaturated carbonyl and Keap1. Phytother Res 2018,32(5),892-897","journal-title":"Phytother Res"},{"key":"ref=302","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.3390\/molecules24112073","volume":"24","author":"Cui H.","year":"2019","unstructured":"Cui H.; Zhang B.; Li G.; Li L.; Chen H.; Qi J.; Liu W.; Chen J.; Wang P.; Lei H.; Identification of a quality marker of vinegar-Processed Curcuma zedoaria on oxidative liver injury. Molecules 2019,24(11),2073","journal-title":"Molecules"},{"key":"ref=303","first-page":"323","volume":"2011","author":"Wang G.G.","year":"2011","unstructured":"Wang G.G.; Lu X.H.; Li W.; Zhao X.; Zhang C.; Protective effects of luteolin on diabetic nephropathy in STZ-induced diabetic rats. Evid.-based Complement. Altern Med 2011,2011,323-171","journal-title":"Altern Med"},{"key":"ref=304","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2019.03.073","volume":"225","author":"Yu Q.","year":"2019","unstructured":"Yu Q.; Zhang M.; Qian L.; Wen D.; Wu G.; Luteolin attenuates high glucose-induced podocyte injury via suppressing NLRP3 inflammasome pathway. Life Sci 2019,225,1-7","journal-title":"Life Sci"},{"key":"ref=305","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.biopha.2017.03.102","volume":"90","author":"Iskender H.","year":"2017","unstructured":"Iskender H.; Dokumacioglu E.; Sen T.M.; Ince I.; Kanbay Y.; Saral S.; The effect of hesperidin and quercetin on oxidative stress, NF-\u03baB and SIRT1 levels in a STZ-induced experimental diabetes model. Biomed Pharmacother 2017,90,500-508","journal-title":"Biomed Pharmacother"},{"key":"ref=306","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/0960327114531995","volume":"34","author":"Elbe H.","year":"2015","unstructured":"Elbe H.; Vardi N.; Esrefoglu M.; Ates B.; Yologlu S.; Taskapan C.; Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats. Hum Exp Toxicol 2015,34(1),100-113","journal-title":"Hum Exp Toxicol"},{"key":"ref=307","doi-asserted-by":"publisher","first-page":"e38285","DOI":"10.1371\/journal.pone.0038285","volume":"7","author":"Wang C.","year":"2012","unstructured":"Wang C.; Pan Y.; Zhang Q.Y.; Wang F.M.; Kong L.D.; Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation. PLoS One 2012,7(6),e38285","journal-title":"PLoS One"},{"key":"ref=308","doi-asserted-by":"publisher","first-page":"F1080","DOI":"10.1152\/ajprenal.90767.2008","volume":"297","author":"Hu Q.H.","year":"2009","unstructured":"Hu Q.H.; Wang C.; Li J.M.; Zhang D.M.; Kong L.D.; Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: renal organic ion transporter involvement. Am J Physiol Renal Physiol 2009,297(4),F1080-F1091","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref=309","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.taap.2014.05.014","volume":"279","author":"Kandasamy N.","year":"2014","unstructured":"Kandasamy N.; Ashokkumar N.; Protective effect of bioflavonoid myricetin enhances carbohydrate metabolic enzymes and insulin signaling molecules in streptozotocin\u2013cadmium induced diabetic nephrotoxic rats. Toxicol Appl Pharmacol 2014,279(2),173-185","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=310","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejphar.2014.09.014","volume":"743","author":"Kandasamy N.","year":"2014","unstructured":"Kandasamy N.; Ashokkumar N.; Renoprotective effect of myricetin restrains dyslipidemia and renal mesangial cell proliferation by the suppression of sterol regulatory element binding proteins in an experimental model of diabetic nephropathy. Eur J Pharmacol 2014,743,53-62","journal-title":"Eur J Pharmacol"},{"key":"ref=311","doi-asserted-by":"publisher","first-page":"113553","DOI":"10.1016\/j.jep.2020.113553","volume":"268","author":"Luo W.","year":"2021","unstructured":"Luo W.; Chen X.; Ye L.; Chen X.; Jia W.; Zhao Y.; Samorodov A.V.; Zhang Y.; Hu X.; Zhuang F.; Qian J.; Zheng C.; Liang G.; Wang Y.; Kaempferol attenuates streptozotocin-induced diabetic nephropathy by downregulating TRAF6 expression: The role of TRAF6 in diabetic nephropathy. J Ethnopharmacol 2021,268,113553","journal-title":"J Ethnopharmacol"},{"key":"ref=312","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10238-011-0167-0","volume":"12","author":"Ozcan F.","year":"2012","unstructured":"Ozcan F.; Ozmen A.; Akkaya B.; Aliciguzel Y.; Aslan M.; Beneficial effect of myricetin on renal functions in streptozotocin-induced diabetes. Clin Exp Med 2012,12(4),265-272","journal-title":"Clin Exp Med"},{"key":"ref=313","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1016\/j.sjbs.2020.11.090","volume":"28","author":"Yang L.","year":"2021","unstructured":"Yang L.; Liao M.; Influence of myrcene on inflammation, matrix accumulation in the kidney tissues of streptozotocin-induced diabetic rat. Saudi J Biol Sci 2021,28(10),5555-5560","journal-title":"Saudi J Biol Sci"},{"key":"ref=314","author":"Zhongliu Y.","year":"1994","unstructured":"Zhongliu Y.; Cancer Review 1994","journal-title":"Cancer Review"},{"key":"ref=315","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3390\/plants9060770","volume":"9","author":"Senthil Kumar K.J.","year":"2020","unstructured":"Senthil Kumar K.J.; Gokila Vani M.; Wang C.S.; Chen C.C.; Chen Y.C.; Lu L.P.; Huang C.H.; Lai C.S.; Wang S.Y.; Geranium and lemon essential oils and their active compounds downregulate angiotensin-converting enzyme 2 (ACE2), a SARS-CoV-2 spike receptor-binding domain, in epithelial cells. Plants 2020,9(6),770","journal-title":"Plants"},{"key":"ref=316","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.3390\/nu11112761","volume":"11","author":"Kim H.R.","year":"2019","unstructured":"Kim H.R.; Kim W.K.; Ha A.W.; Effects of phytochemicals on blood pressure and neuroprotection mediated via brain renin-angiotensin system. Nutrients 2019,11(11),2761","journal-title":"Nutrients"},{"key":"ref=317","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/mnfr.201500751","volume":"60","author":"Jones H.S.","year":"2016","unstructured":"Jones H.S.; Gordon A.; Magwenzi S.G.; Naseem K.; Atkin S.L.; Courts F.L.; The dietary flavonol quercetin ameliorates angiotensin II-induced redox signaling imbalance in a human umbilical vein endothelial cell model of endothelial dysfunction via ablation of p47 phox expression. Mol Nutr Food Res 2016,60(4),787-797","journal-title":"Mol Nutr Food Res"},{"key":"ref=318","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.foodres.2017.07.019","volume":"100","author":"Luo J.","year":"2017","unstructured":"Luo J.; Zhang C.; Liu Q.; Ou S.; Zhang L.; Peng X.; Combinative effect of sardine peptides and quercetin alleviates hypertension through inhibition of angiotensin I converting enzyme activity and inflammation. Food Res Int 2017,100(Pt 1),579-585","journal-title":"Food Res Int"},{"key":"ref=319","doi-asserted-by":"publisher","first-page":"1700772","DOI":"10.1002\/mnfr.201700772","volume":"62","author":"Guo X.","year":"2018","unstructured":"Guo X.; Chen M.; Zeng H.; Liu P.; Zhu X.; Zhou F.; Liu J.; Zhang J.; Dong Z.; Tang Y.; Gao C.; Yao P.; Quercetin attenuates ethanol-induced iron uptake and myocardial injury by regulating the angiotensin II-L-type calcium channel. Mol Nutr Food Res 2018,62(5),1700772","journal-title":"Mol Nutr Food Res"},{"key":"ref=320","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3390\/ijms18051001","volume":"18","author":"Suchal K.","year":"2017","unstructured":"Suchal K.; Malik S.; Khan S.; Malhotra R.; Goyal S.; Bhatia J.; Ojha S.; Arya D.; Molecular pathways involved in the amelioration of myocardial injury in diabetic rats by kaempferol. Int J Mol Sci 2017,18(5),1001","journal-title":"Int J Mol Sci"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666230519112312","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/217082\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666230519112312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T20:50:58Z","timestamp":1729457458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/217082\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":320,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867330666230519112312","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-12-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}